124 results on '"Johan Permert"'
Search Results
2. Pancreatectomies for pancreatic neoplasms in pediatric and adolescent age: A single institution experience
- Author
-
Jakob Stenman, Roberto Valente, Ralf Segersvärd, Johan Permert, Chiara Scandavini, Marco Del Chiaro, Pär-Johan Svensson, Elena Rangelova, and Urban Arnelo
- Subjects
Male ,medicine.medical_specialty ,Adolescent ,Endocrinology, Diabetes and Metabolism ,Pancreatoblastoma ,pancreatic resections ,pancreatic surgery ,pancreatic tumors ,pediatric pancreatic surgery ,pediatric pancreatic tumors ,adolescent ,child ,child, preschool ,female ,humans ,male ,pancreatectomy ,pancreatic neoplasms ,pancreaticoduodenectomy ,postoperative complications ,treatment outcome ,endocrinology, diabetes and metabolism ,hepatology ,gastroenterology ,Adolescent age ,Pancreaticoduodenectomy ,Pancreatic surgery ,03 medical and health sciences ,Pancreatectomy ,Postoperative Complications ,0302 clinical medicine ,Pediatric surgery ,medicine ,Humans ,Endocrine system ,Ganglioneuroma ,Child ,Insulinoma ,Hepatology ,business.industry ,Gastroenterology ,Retrospective cohort study ,medicine.disease ,Surgery ,Pancreatic Neoplasms ,Treatment Outcome ,Child, Preschool ,030220 oncology & carcinogenesis ,Female ,030211 gastroenterology & hepatology ,business - Abstract
Background There are very few data in the current literature regarding the short- and long-term outcome of surgery for pediatric pancreatic tumors (PPT). No data are available on the impact of pancreatic surgery on the children's growth. Methods This is a retrospective cohort study on a consecutive series of pediatric/adolescent patients who underwent pediatric surgery at Karolinska University Hospital from January 2005 to July 2017. Results Overall 14 pancreatic operations were performed in 13 patients. The median age was 11.4 years (range 3–15). Six pancreaticoduodenectomies (42.8%), 5 distal pancreatectomies (35.7%), and 3 enucleations (21.5%) were performed. The final histology revealed a solid pseudopapillary tumor in 9 cases (69.2%), neuroblastoma in 1 (7.7%), ganglioneuroma in 1 (7.7%), pancreatoblastoma in 1 (7.7%), and insulinoma in 1 (7.7%). Overall, 3 patients developed post-operative complications (23%). There was no peri-operative mortality. All patients are alive after a median follow-up time of 80 months. Exocrine insufficiency was detected post-operatively in 4 patients (30.7%) Endocrine insufficiency requiring insulin treatment developed in one patient (7.7%). No significant impact on growth was detected in any of the patients after pancreatic resection. Conclusions In our series, surgery performed for PPTs seems to be safe and effective. The effect of pancreatic surgery on children's growth does not seem to be significant.
- Published
- 2018
3. Transplantation of tissue‐engineered cell sheets for stricture prevention after endoscopic submucosal dissection of the oesophagus
- Author
-
Eduard Jonas, Magnus Nilsson, Mei Ling Lim, Pontus Blomberg, Peter Elbe, Teruo Okano, Makoto Kondo, Stephan L. Haas, J-Matthias Löhr, Jenny Enger, Takeshi Ohki, Johan Permert, Masayuki Yamato, Nobuo Kanai, Katrin Markland, Ryo Takagi, Sebastian Sjöqvist, Masakazu Yamamoto, and Ammar Mohkles-Barakat
- Subjects
medicine.medical_specialty ,Tissue engineered ,business.industry ,Gastroenterology ,Treatment options ,Original Articles ,Endoscopic submucosal dissection ,Dissection (medical) ,medicine.disease ,digestive system diseases ,Surgery ,Transplantation ,03 medical and health sciences ,0302 clinical medicine ,Oncology ,030220 oncology & carcinogenesis ,Barrett's oesophagus ,medicine ,030211 gastroenterology & hepatology ,business ,Cell sheet - Abstract
Endoscopic mucosal dissection (ESD) is a treatment option for oesophagus tumours localized to the mucosa enabling en bloc removal of large lesions. The resulting larger mucosal defects have resulted in an increase in the occurrence of post-treatment strictures. Transplantation of autologous cell sheets, cultured from oral mucosa, has been shown to prevent post-ESD strictures. The aim of the study was to assess the efficacy and safety of cell sheet transplantation after oesophageal ESD in a Western patient population where reflux-associated pre-malignant and malignant conditions predominate.Patients with Barrett's oesophagus associated high-grade dysplasia or early adenocarcinoma where ESD entailed a resection3 cm in length and ≥75% of the circumference were eligible for treatment under hospital exemption. Cell sheets were cultured from buccal mucosa according to Good Manufacturing Practice and were endoscopically applied to the post-ESD defect directly after resection. Patients were followed with weekly endoscopy examinations, including confocal laser microscopy, for a total of four weeks.Five patients were treated. ESD was extensive with resections being circumferential in three patients and 9-10 cm in length in two. The number of transplanted cell sheets ranged from two to six. Three patients developed strictures requiring two to five dilatation sessions.Cell sheet transplantation shows to be safe and feasible in a Western population. Results suggest that transplantation has a protective effect on the mucosal defect after ESD, decreasing both the risk for and extent of stricture formation.
- Published
- 2016
4. A Preliminary Report: Radical Surgery and Stem Cell Transplantation for the Treatment of Patients With Pancreatic Cancer
- Author
-
Jochen M. Schwenk, Rainer Heuchel, Johan Permert, Burcu Ayoglu, Sam Ghazi, Isabelle Magalhaes, Brigitta Omazic, Markus Maeurer, Jonas Mattsson, Zuzana Potácová, Ralf Segersvärd, Nils Albiin, Liu Zhenjiang, Thomas Poiret, Caroline S. Verbeke, Peter Nilsson, Matthias Löhr, Alexei Terman, Olle Ringdén, and Nikolaos Kartalis
- Subjects
0301 basic medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,Pathology ,medicine.medical_treatment ,Immunology ,Hematopoietic stem cell transplantation ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,Internal medicine ,Pancreatic cancer ,Immunology and Allergy ,Medicine ,Radical surgery ,Survival rate ,Pharmacology ,business.industry ,medicine.disease ,Transplantation ,surgical procedures, operative ,030104 developmental biology ,030220 oncology & carcinogenesis ,Adenocarcinoma ,business ,Progressive disease - Abstract
We examined the immunologic effects of allogeneic hematopoietic stem cell transplantation (HSCT) in the treatment of pancreatic ductal adenocarcinoma, a deadly disease with a median survival of 24 months for resected tumors and a 5-year survival rate of 6%. After adjuvant chemotherapy, 2 patients with resected pancreatic ductal adenocarcinoma underwent HSCT with HLA-identical sibling donors. Comparable patients who underwent radical surgery, but did not have a donor, served as controls (n=6). Both patients developed humoral and cellular (ie, HLA-A*01:01-restricted) immune responses directed against 2 novel tumor-associated antigens (TAAs), INO80E and UCLH3 after HSCT. Both TAAs were highly expressed in the original tumor tissue suggesting that HSCT promoted a clinically relevant, long-lasting cellular immune response. In contrast to untreated controls, who succumbed to progressive disease, both patients are tumor-free 9 years after diagnosis. Radical surgery combined with HSCT may cure pancreatic adenocarcinoma and change the cellular immune repertoire capable of responding to clinically and biologically relevant TAAs.
- Published
- 2017
5. Pancreatic Exocrine Insufficiency in Pancreatic Cancer
- Author
-
Johan Permert, J.-Matthias Löhr, Roberto Valente, Marco Del Chiaro, and Miroslav Vujasinovic
- Subjects
medicine.medical_specialty ,exocrine insufficiency ,media_common.quotation_subject ,pancreatic cancer ,lcsh:TX341-641 ,Review ,malnutrition ,Gastroenterology ,Cachexia ,03 medical and health sciences ,0302 clinical medicine ,pancreas cancer ,Weight loss ,Internal medicine ,Pancreatic cancer ,medicine ,Humans ,Enzyme Replacement Therapy ,pancreas ,pancreatic surgery ,media_common ,Randomized Controlled Trials as Topic ,pancreatic exocrine insufficiency ,Nutrition and Dietetics ,business.industry ,vitamin ,Cancer ,Appetite ,Vitamins ,medicine.disease ,Warburg effect ,Pancreatic Neoplasms ,Malnutrition ,Endocrinology ,medicine.anatomical_structure ,exocrine insufficiency, pancreas, pancreas cancer ,030220 oncology & carcinogenesis ,030211 gastroenterology & hepatology ,Exocrine Pancreatic Insufficiency ,medicine.symptom ,Pancreas ,business ,lcsh:Nutrition. Foods and food supply ,Food Science - Abstract
Cancer patients experience weight loss for a variety of reasons, commencing with the tumor’s metabolism (Warburg effect) and proceeding via cachexia to loss of appetite. In pancreatic cancer, several other factors are involved, including a loss of appetite with a particular aversion to meat and the incapacity of the pancreatic gland to function normally when a tumor is present in the pancreatic head. Pancreatic exocrine insufficiency is characterized by a deficiency of the enzymes secreted from the pancreas due to the obstructive tumor, resulting in maldigestion. This, in turn, contributes to malnutrition, specifically a lack of fat-soluble vitamins, antioxidants, and other micronutrients. Patients with pancreatic cancer and pancreatic exocrine insufficiency have, overall, an extremely poor prognosis with regard to surgical outcome and overall survival. Therefore, it is crucial to be aware of the mechanisms involved in the disease, to be able to diagnose pancreatic exocrine insufficiency early on, and to treat malnutrition appropriately, for example, with pancreatic enzymes.
- Published
- 2017
6. Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinsons Disease
- Author
-
Jörgen Larsson, Peter Grenholm, Håkan Widner, Thomas Willows, Kristina Groth, Johan Permert, Susanna Kjellander, Ursula Schmiauke, Nil Dizdar, Dag Nyholm, and Anna Urbom
- Subjects
Male ,Research Report ,Time Factors ,Neurology ,Parkinson's disease ,020205 medical informatics ,Neurologi ,Video Recording ,Advanced Parkinsons disease ,levodopa-carbidopa intestinal gel ,LCIG ,duodenal levodopa-carbidopa infusion ,Duodopa ,telemedicine ,video communication system ,home titration ,routine patient care ,healthcare resource utilization ,02 engineering and technology ,Antiparkinson Agents ,Levodopa ,0302 clinical medicine ,0202 electrical engineering, electronic engineering, information engineering ,Carbidopa ,Parkinson Disease ,Middle Aged ,Telemedicine ,Intestines ,Drug Combinations ,Treatment Outcome ,Female ,medicine.drug ,medicine.medical_specialty ,Nursing ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,medicine ,Humans ,In patient ,Adverse effect ,Video communication system ,Aged ,Sweden ,Advanced Parkinson’s disease ,business.industry ,Omvårdnad ,medicine.disease ,Advanced Parkinson's disease ,Physical therapy ,Neurology (clinical) ,business ,Gels ,030217 neurology & neurosurgery - Abstract
Background: Levodopa-carbidopa intestinal gel (LCIG; Duodopa r) is used for continuous infusion in advanced Parkinsons disease. To achieve optimal effect, the LCIG dose is individually titrated, traditionally conducted during hospitalization in Sweden. However, dose adjustment depends on surrounding conditions, physical activity, and emotional stress, which is why titration at home could be beneficial. Telemedicine (TM) using a video communication system offers alternative titration procedures, allowing LCIG initiation at home. Objective: Study objectives were to show the feasibility of TM for LCIG home titration, evaluate resource use, and assess patient, neurologist, and nurse satisfaction. Methods: Four clinics enrolled 15 patients to observe efficiency and feasibility of TM-based monitoring. Results: Patient median (range) age was 67 (52-73) years and time since diagnosis was 10 (7-23) years. Median time between LCIG initiation and end of TM-assisted titration was 2.8 (2.0-13.8) days. Median time required for home titration by neurologists, nurses, and patients was (hours: minutes) 1 : 14 (0 : 29-1 : 52), 5 : 49 (2 : 46-10 : 3), and 8 : 53 (4 : 11-14 : 11), respectively. Neurologists and nurses considered this to be less time than required for hospital titration. TM allowed patients 92% free time from start to end of titration. Technical problems associated with TM contacts were rare, mostly related to digital link, and quickly resolved. Patients, neurologists, and nurses were satisfied using TM. No serious adverse events were reported; there was one device complaint (tube occlusion). Conclusions: In this study, TM-assisted LCIG titration at home was resource-efficient, technically feasible, well-accepted and was deemed satisfactory by patients, neurologists, and nurses. Funding Agencies|AbbVie AB
- Published
- 2017
7. Telemedicine: an important aid to perform high-quality endoscopic retrograde cholangiopancreatography in low-volume centers
- Author
-
Matthias Löhr, Lars Enochsson, Urban Arnelo, Lars Lundell, H. I. Påhlsson, Kristina Groth, Fredrik Swahn, and Johan Permert
- Subjects
Adult ,Male ,Ampulla of Vater ,medicine.medical_specialty ,Telemedicine ,Hospitals, Low-Volume ,Attitude of Health Personnel ,Biliary Tract Diseases ,medicine.medical_treatment ,Operative Time ,Constriction, Pathologic ,Gallstones ,Digestive System Neoplasms ,Percutaneous transhepatic cholangiography ,Catheterization ,medicine ,Humans ,Common bile duct stone ,In patient ,Aged ,Aged, 80 and over ,Cholangiopancreatography, Endoscopic Retrograde ,Cholestasis ,Endoscopic retrograde cholangiopancreatography ,medicine.diagnostic_test ,business.industry ,Gastroenterology ,food and beverages ,Middle Aged ,medicine.disease ,Surgery ,Low volume ,Female ,Rural Health Services ,Medical emergency ,business ,Health care quality - Abstract
The aim of this study was to investigate whether telemedicine can help to ensure high-quality endoscopic retrograde cholangiopancreatography (ERCP) in patients living in rural areas. The study was conducted by investigators from two centers: the Karolinska University Hospital, a high-volume center which provided the teleguided support, and the Visby District Hospital, a low-volume center.From September 2010 to August 2011, 26 ERCP procedures performed at a district hospital were teleguided by an experienced endoscopist at the Karolinska University Hospital. To ensure patient data protection, all communication went through a network (Sjunet) that was separate from the Internet and open only to accredited users. The indications for ERCP were common bile duct stones (n = 12), malignant strictures (n = 12), and benign biliary strictures (n = 2). In 15 cases, this was the patient's first ERCP procedure.The common bile duct was successfully cannulated in all 26 teleguided procedures. The local endoscopist scored the teleguided support as crucial for the successful outcome in 8 /26 cases, as an important factor in 8, and as being of less importance in the remaining 10. In the eight cases where the teleguided support was judged to be crucial, six subsequent percutaneous transhepatic cholangiography procedures and two repeat ERCPs were avoided. The overall cannulation rate at the district hospital improved from 85 % to 99 % after teleguided support was introduced. No procedure-related complications occurred.Distant guidance of advanced ERCP procedures in a low-volume center, through teleguided support from a high-volume center, has the potential to improve the quality of care, as reflected in high cannulation rates and the ability to complete the scheduled interventions.
- Published
- 2013
8. Clinical and Experimental Pancreatic Islet Transplantation to Striated Muscle
- Author
-
Ralf Segersvärd, Per-Ola Carlsson, José Caballero-Corbalán, Johanna Henriksnäs, Mia Phillipson, Johan Permert, Charlotte Rolny, Håkan Ahlström, Olle Korsgren, Gustaf Christoffersson, and Lars Johansson
- Subjects
Blood Glucose ,Male ,Reoperation ,medicine.medical_specialty ,endocrine system ,Graft failure ,Transplantation, Heterotopic ,endocrine system diseases ,Neutrophils ,Endocrinology, Diabetes and Metabolism ,Islets of Langerhans Transplantation ,Mice, Nude ,Cell Separation ,Transplantation, Autologous ,Diabetes Mellitus, Experimental ,Islets of Langerhans ,Mice ,Adenosine Triphosphate ,Organ Culture Techniques ,Diabetes mellitus ,Internal medicine ,Internal Medicine ,medicine ,Leukocytes ,Animals ,Muscle, Skeletal ,geography ,Type 1 diabetes ,geography.geographical_feature_category ,business.industry ,Pancreatic islets ,medicine.disease ,Islet ,Transplantation ,Adenosine Diphosphate ,Mice, Inbred C57BL ,medicine.anatomical_structure ,Endocrinology ,Pancreatic islet transplantation ,Immunology and Transplantation ,Leukocyte Reduction Procedures ,Pancreas ,business - Abstract
OBJECTIVE Curing type 1 diabetes by transplanting pancreatic islets into the liver is associated with poor long-term outcome and graft failure at least partly due to inadequate graft revascularization. The aim of the current study was to evaluate striated muscle as a potential angiogenic site for islet transplantation. RESEARCH DESIGN AND METHODS The current study presents a new experimental model that is found to be applicable to clinical islet transplantation. Islets were implanted into striated muscle and intraislet vascular density and blood flow were visualized with intravital and confocal microscopy in mice and by magnetic resonance imaging in three autotransplanted pancreatectomized patients. Mice were rendered neutropenic by repeated injections of Gr-1 antibody, and diabetes was induced by alloxan treatment. RESULTS Contrary to liver-engrafted islets, islets transplanted to mouse muscle were revascularized with vessel densities and blood flow entirely comparable with those of islets within intact pancreas. Initiation of islet revascularization at the muscular site was dependent on neutrophils, and the function of islets transplanted to muscle was proven by curing diabetic mice. The experimental data were confirmed in autotransplanted patients where higher plasma volumes were measured in islets engrafted in forearm muscle compared with adjacent muscle tissue through high-resolution magnetic resonance imaging. CONCLUSIONS This study presents a novel paradigm in islet transplantation whereby recruited neutrophils are crucial for the functionally restored intraislet blood perfusion following transplantation to striated muscle under experimental and clinical situations.
- Published
- 2010
9. 42nd European Pancreatic Club (EPC) Meeting
- Author
-
Johan Permert, Ralf Segersvärd, and J.-Matthias Löhr
- Subjects
Oncology ,medicine.medical_specialty ,Hepatology ,business.industry ,Endocrinology, Diabetes and Metabolism ,Inflammatory response ,Gastroenterology ,Cancer ,medicine.disease ,Internal medicine ,Pancreatic cancer ,Medicine ,In patient ,business ,Anaerobic exercise - Published
- 2010
10. Pancreatic duct changes are not associated with early signs of chronic pancreatitis at magnetic resonance imaging (MRI) in patients with primary sclerosing cholangitis
- Author
-
Torkel B. Brismar, B. O. Lindberg, Annika Bergquist, Azza Karrar, Nils Albiin, Johan Permert, and Karouk Said
- Subjects
Male ,medicine.medical_specialty ,Pancreatic disease ,Early signs ,Cholangitis, Sclerosing ,Gastroenterology ,Primary sclerosing cholangitis ,Pancreatitis, Chronic ,Internal medicine ,medicine ,Humans ,Pancreatic duct ,medicine.diagnostic_test ,business.industry ,Pancreatic Ducts ,Magnetic resonance imaging ,Middle Aged ,medicine.disease ,Magnetic Resonance Imaging ,medicine.anatomical_structure ,Pancreatitis ,Female ,sense organs ,Pancreas ,business ,Duct (anatomy) - Abstract
The association between chronic pancreatitis (CP) and primary sclerosing cholangitis (PSC) has been reported previously. The aims of the present study were to evaluate the presence of early pancreatic abnormalities and duct changes, using MRCP/MRI in PSC and to evaluate possible risk factors for these changes and their clinical importance.One hundred and three patients with PSC were identified among all MRI liver/pancreas referrals in 2001-2005. MRCP was used to grade pancreatic duct changes in three groups: grade 0 (normal), grade 1 (mild) and grade 2 (severe). For detection of early MRI signs of CP, the pancreas-spleen signal intensity ratio (SIR), the arterial and early venous phase ratio (A/PV ratio) and the age-related size of the pancreas were evaluated.Pancreatic duct changes were found in 24% of the PSC patients. The pancreatic duct changes were associated with extrahepatic biliary involvement and long duration of PSC but not associated with pancreas-spleen SIR, A/PV ratio, pancreas size, previous post-ERCP or acute pancreatitis. Severe pancreatic duct changes were significantly associated to abdominal pain. Clinically significant CP was seen in one PSC patient (1%).Pancreatic duct changes are associated with extrahepatic bile duct strictures and not with the early MRI signs of CP. Therefore, pancreatic duct changes seem to be part of the spectrum of PSC and should not be defined as CP. Pancreatic duct changes are of limited clinical importance but may contribute to abdominal pain in PSC.
- Published
- 2010
11. Adipose tissue pathways involved in weight loss of cancer cachexia
- Author
-
Natasa Petrovic, David M. Mutch, Agné Kulyté, Mikael Rydén, Niklas Mejhert, Karin Dahlman-Wright, Jan Nedergaard, Johan Permert, Thorhallur Agustsson, Ingrid Dahlman, Peter Arner, Bengt Isaksson, Eva Sjölin, David Brodin, K Linder, and Karine Clément
- Subjects
Male ,Cancer Research ,medicine.medical_specialty ,Cachexia ,extracellular matrix ,wasting ,Adipose tissue ,Gene Expression ,Biology ,Extracellular matrix ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Weight loss ,Adipocyte ,Internal medicine ,Neoplasms ,Gene expression ,Weight Loss ,medicine ,Humans ,Obesity ,Cell adhesion ,Molecular Diagnostics ,030304 developmental biology ,Aged ,Oligonucleotide Array Sequence Analysis ,0303 health sciences ,Reverse Transcriptase Polymerase Chain Reaction ,Gene Expression Profiling ,cellular adhesion ,medicine.disease ,Actin cytoskeleton ,adipose tissue ,Endocrinology ,Oncology ,chemistry ,Gene Expression Regulation ,030220 oncology & carcinogenesis ,Female ,medicine.symptom ,microarray ,Signal Transduction - Abstract
Background: The regulatory gene pathways that accompany loss of adipose tissue in cancer cachexia are unknown and were explored using pangenomic transcriptome profiling. Methods: Global gene expression profiles of abdominal subcutaneous adipose tissue were studied in gastrointestinal cancer patients with (n=13) or without (n=14) cachexia. Results: Cachexia was accompanied by preferential loss of adipose tissue and decreased fat cell volume, but not number. Adipose tissue pathways regulating energy turnover were upregulated, whereas genes in pathways related to cell and tissue structure (cellular adhesion, extracellular matrix and actin cytoskeleton) were downregulated in cachectic patients. Transcriptional response elements for hepatic nuclear factor-4 (HNF4) were overrepresented in the promoters of extracellular matrix and adhesion molecule genes, and adipose HNF4 mRNA was downregulated in cachexia. Conclusions: Cancer cachexia is characterised by preferential loss of adipose tissue; muscle mass is less affected. Loss of adipose tissue is secondary to a decrease in adipocyte lipid content and associates with changes in the expression of genes that regulate energy turnover, cytoskeleton and extracellular matrix, which suggest high tissue remodelling. Changes in gene expression in cachexia are reciprocal to those observed in obesity, suggesting that regulation of fat mass at least partly corresponds to two sides of the same coin.
- Published
- 2010
12. Bile duct obstruction is associated with early postoperative upregulation of liver uncoupling protein-2 and reduced circulating glucose concentration in the rat
- Author
-
Bengt Isaksson, Johan Permert, Lovisa Strömmer, Charlotte Erlanson-Albertsson, and Lars Enochsson
- Subjects
Blood Glucose ,Male ,Muscle tissue ,medicine.medical_specialty ,Bilirubin ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Fatty Acids, Nonesterified ,Biology ,Hypoglycemia ,Ion Channels ,Mitochondrial Proteins ,Rats, Sprague-Dawley ,chemistry.chemical_compound ,Adenosine Triphosphate ,Downregulation and upregulation ,Internal medicine ,Blood plasma ,medicine ,Animals ,Insulin ,Uncoupling protein ,Uncoupling Protein 2 ,Postoperative Period ,Muscle, Skeletal ,Cholestasis ,Nutrition and Dietetics ,Bile duct ,Blotting, Northern ,medicine.disease ,Rats ,Up-Regulation ,Disease Models, Animal ,medicine.anatomical_structure ,Endocrinology ,Liver ,chemistry - Abstract
Objective: To evaluate whether upregulation of liver and muscle uncoupling protein 2 (UCP-2) is an acute phenomenon in obstructive jaundice and associated with secondary metabolic effects. Methods: Male Sprague-Dawley rats were divided into four groups bile duct ligated (BDL) and sham-operated pair-fed (PF), ad libitum fed (AL), and controls BDL. PF. and AL rats were further divided into subgroups according to the interval postoperatively when they were reanesthetized and sampled for tissue and blood 2, 4, and 8 d, respectively Bilirubin, liver enzymes. glucose, free fatty acids, and insulin in blood plasma were analyzed Liver and muscle tissue were sampled for UCP-2 and adenosine triphosphate analysis. Results: The BDL rats showed an increase of the liver UCP-2 expression compared with PF and AL rats (P < 0 05) 4 d postoperatively. Liver adenosine triphosphate in BDL rats showed a decrease compared with sham-operated controls at all intervals < 0 05) Plasma glucose concentration in BDL rats was decreased compared with the other groups. Free fatty acids showed an initial increase 2 d postoperatively compared with sham-operated controls and PF and AL rats (P < 0 05) at the corresponding time point Conclusion: Obstructive jaundice is associated with an early upregulation of liver UCP-2. reduced liver adenosine triphosphate content, and decreased plasma glucose concentration, supporting the hypothesis that obstructive Jaundice results in impaired energy homeostasis in the liver. which might cause decreased glucose output and hypoglycemia as a consequence (C) 2010 Elsevier Inc. All flats reserved (Less)
- Published
- 2010
13. The use of artificial nutrition among cancer patients enrolled in palliative home care services
- Author
-
Johan Permert, Carol Tishelman, Ylva Orrevall, and Tommy Cederholm
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pediatrics ,Nausea ,MEDLINE ,Artificial nutrition ,Enteral Nutrition ,Neoplasms ,medicine ,Humans ,Intensive care medicine ,Head and neck ,Aged ,Enteral Tube Feeding ,Aged, 80 and over ,business.industry ,Palliative Care ,Cancer ,General Medicine ,Middle Aged ,medicine.disease ,Home Care Services ,Logistic Models ,Anesthesiology and Pain Medicine ,Parenteral nutrition ,Vomiting ,Female ,medicine.symptom ,Parenteral Nutrition, Home ,business - Abstract
In this study, patients’ views and experiences of using home artificial nutrition, and factors associated with use of home parenteral nutrition (HPN) were investigated. Structured telephone interviews with 620 cancer patients enrolled in 21 palliative home care services were analysed. HPN was more common (11%) than home enteral tube feeding (HETF, 3%). Home artificial nutrition (including HPN and HETF) was usually introduced more than four months before death. Three of four HPN recipients also had oral food intake. HPN use was associated with eating difficulties, nausea/vomiting, and fatigue rather than gastrointestinal problems per se. HETF was generally used for patients with problems related to oesophagus and head and neck tumours. In conclusion the results suggest that, contrary to existing guidelines, HPN is used to supplement oral intake, and not only for patients with a non-functioning gastrointestinal tract.
- Published
- 2009
14. EVALUATION OF A COMPLICATION GRADING SYSTEM FOR PANCREATIC SURGERY
- Author
-
L. Strömmer, Ralf Segersvärd, Johan Permert, Christoph Ansorge, Elena Rangelova, and Å. Andrén-Sandberg
- Subjects
medicine.medical_specialty ,Endocrinology ,Hepatology ,business.industry ,Endocrinology, Diabetes and Metabolism ,Internal Medicine ,medicine ,Complication ,business ,Pancreatic surgery ,Surgery - Published
- 2008
15. Lipolysis-Not inflammation, cell death, or lipogenesis-Is involved in adipose tissue loss in cancer cachexia
- Author
-
Bengt Isaksson, Johan Permert, Thorhallur Agustsson, Mikael Rydén, Peter Arner, Tom Britton, Eva Sjölin, and Jurga Laurencikiene
- Subjects
Male ,Cancer Research ,medicine.medical_specialty ,Cachexia ,Adipose Tissue, White ,Lipolysis ,Adipose tissue ,Cell Count ,Inflammation ,chemistry.chemical_compound ,Lymphocytes, Tumor-Infiltrating ,Neoplasms ,Internal medicine ,Adipocyte ,Adipocytes ,medicine ,Humans ,Aged ,Cell Death ,Interleukin-6 ,Adipose tissue loss ,business.industry ,Lipogenesis ,digestive, oral, and skin physiology ,Cancer ,Middle Aged ,musculoskeletal system ,medicine.disease ,Endocrinology ,Oncology ,chemistry ,Cytokines ,Female ,medicine.symptom ,business - Abstract
Cancer cachexia is an important, negative prognostic marker that has been linked to systemic inflammation and cell death through unclear mechanisms. A key feature of cancer cachexia is loss of white adipose tissue (WAT) because of increased adipocyte lipolysis and possibly reduced lipid synthesis (lipogenesis). In this study, the authors investigated whether alterations in fat cell numbers, lipogenesis, or cytokine and/or leukocyte infiltration could account for some of the functional changes observed in WAT in cancer cachexia.Blood and subcutaneous WAT samples were obtained from a 10 weight-stable patients, from 13 weight losing (cachexia) patients with cancer, and from 5 patients without cancer (noncancer patients) who initially were classified with cancer.Systemic inflammation (increased circulating levels of interleukin 6 [IL-6]) and enhanced lipolysis were confirmed in the cachectic patients compared with the other patients. However, the messenger RNA expression of IL-6 and other cytokine or leukocyte markers, as well as WAT secretion of IL-6, were not altered in the patients with cachexia. Thus, the elevated serum levels of IL-6 that were observed in cachexia were not derived from WAT. Insulin-induced lipogenesis in adipocytes from patients with cachexia was the same as that in adipocytes from patients with weight-stable cancer and from noncancer patients (2.5-fold maximal stimulation; half-maximum effective concentration, approximately 0.03 nmol/L). Fat cell size was decreased but adipocyte numbers were normal in cancer patients with cachexia, suggesting that there was no major fat cell death.The current findings indicated that subcutaneous WAT does not contribute to the systemic inflammatory reaction and does not induce adipocyte insulin resistance in cancer cachexia. Moreover, increased fat cell lipolysis, not reduced lipogenesis or adipocyte cell death, appeared to be the primary cause of fat loss in this condition.
- Published
- 2008
16. Nutritional support and risk status among cancer patients in palliative home care services
- Author
-
Ylva Orrevall, Tommy Cederholm, Johan Permert, and Carol Tishelman
- Subjects
Male ,medicine.medical_specialty ,Palliative care ,MEDLINE ,Risk Assessment ,Interviews as Topic ,Neoplasms ,Health care ,Home Care Agencies ,Humans ,Medicine ,Medical nutrition therapy ,Intensive care medicine ,Aged ,business.industry ,Nursing research ,Palliative Care ,Cancer ,Middle Aged ,medicine.disease ,Malnutrition ,Nutrition Assessment ,Oncology ,Family medicine ,Female ,Nutrition Therapy ,Risk assessment ,business - Abstract
The aim of this study was to investigate the nutritional risk status and use of nutritional support among cancer patients enrolled in palliative home care services. Differences in the use of nutritional support in relation to nutritional, social and clinical factors, as well as survival were also investigated.Structured telephone interviews were conducted with cancer patients enrolled in all 21 palliative home care services in the Stockholm region. An interview guide was designed to investigate topics related to the patient's nutritional situation.Interviews with 621 patients were analysed. Sixty-eight percent of the patients were scored as at nutritional risk according on a modified version of NRS-2002. Nutritional support was used by 55% of the patients, with oral nutritional supplements most common and 14% using artificial nutrition. Use of nutritional support was related to low BMI and severe weight loss and was more common in patients with shorter survival times.These findings demonstrate that nutritional support is used to treat already malnourished patients with shorter survival time, rather than to prevent malnutrition. A more structured approach to nutritional issues for patients in palliative phases, which considers life expectancy and psycho-social aspects of nutritional issues, could help identify potential candidates for nutritional support.
- Published
- 2008
17. Intramuscular Autotransplantation of Pancreatic Islets in a 7-Year-Old Child: A 2-Year Follow-Up
- Author
-
Birgit Borgström, M. Rydén, Torbjörn Lundgren, Bengt Isaksson, Bo Nilsson, Johan Permert, Olle Korsgren, Lars Sävendahl, U. Arnelo, Ehab Rafael, and Annika Tibell
- Subjects
medicine.medical_specialty ,Time Factors ,endocrine system diseases ,medicine.medical_treatment ,Islets of Langerhans Transplantation ,Transplantation, Autologous ,Pancreatectomy ,Internal medicine ,Diabetes mellitus ,medicine ,Humans ,Immunology and Allergy ,Pharmacology (medical) ,Child ,Muscle, Skeletal ,Glycated Hemoglobin ,Transplantation ,geography ,geography.geographical_feature_category ,business.industry ,Insulin ,Pancreatic islets ,medicine.disease ,Islet ,Autotransplantation ,Treatment Outcome ,Endocrinology ,medicine.anatomical_structure ,Pancreatitis ,Basal (medicine) ,business ,Follow-Up Studies - Abstract
A 7-year-old girl with severe hereditary pancreatitis underwent total pancreatectomy. A total of 160,000 islet equivalents (6400 islet/kg) were transplanted to the brachioradialis muscle of the right forearm. Her plasma C-peptide level was undetectable after pancreatectomy but increased to 1.37 ng/mL after 17 days; at this time point, her insulin requirement was 0.75 units of insulin/kg/day. At 5- and 27-months, her hemoglobin A1c (HbA1c) and insulin requirements were 4.5 and 5.3% and 0.3 and 0.18 units/kg/day, respectively. Basal and stimulated C-peptide levels were 0.67 +/- 0.07 and 3.36 +/- 1.37 ng/mL, respectively. Stimulated insulin levels were 30% higher in the islet-bearing arm compared to the contralateral arm after glucagon stimulation. After surgery and islet transplantation, the quality of life improved dramatically and she gained 8 kg of weight. In summary, a normal HbA1c, a low insulin requirement and the absence of recurrent hypoglycemia and the gradient of insulin between the arms indicate that the intramuscularly transplanted islets contribute to a long-term clinically significant metabolic control.
- Published
- 2008
18. Mechanism of Increased Lipolysis in Cancer Cachexia
- Author
-
Vanessa van Harmelen, J Hoffstedt, Johan Permert, Bengt Isaksson, Thorhallur Agustsson, Andrea Dicker, Peter Arner, M. Rydén, and Jurga Laurencikiene
- Subjects
Male ,Cancer Research ,medicine.medical_specialty ,Cachexia ,Lipolysis ,medicine.medical_treatment ,Gene Expression ,Adipose tissue ,Biology ,Norepinephrine ,chemistry.chemical_compound ,Weight loss ,Internal medicine ,Adipocyte ,Weight Loss ,Adipocytes ,medicine ,Humans ,Insulin ,RNA, Messenger ,Gastrointestinal Neoplasms ,Cancer ,Sterol Esterase ,medicine.disease ,Endocrinology ,Oncology ,Mechanism of action ,chemistry ,Female ,medicine.symptom ,Atrial Natriuretic Factor - Abstract
Loss of fat mass is a key feature of cancer cachexia and has been attributed to increased adipocyte lipolysis. The mechanism behind this alteration is unknown and was presently investigated. We studied mature s.c. fat cells and differentiated preadipocytes from 26 cancer patients with and without cachexia. Hormone-induced lipolysis and expression of lipolysis-regulating genes were determined together with body composition and in vivo lipolytic activity (fasting plasma glycerol or fatty acids related to body fat). Body fat was reduced by 40% and in vivo lipolytic activity was 2-fold increased in cachexia (P = 0.001). In mature adipocytes, the lipolytic effects of catecholamines and natriuretic peptide were 2- to 3-fold increased in cachexia (P < 0.001). This was completely counteracted by inhibiting the rate-limiting lipolysis enzyme hormone-sensitive lipase (HSL). In cachexia, the expression levels of HSL mRNA and protein were increased by 50% and 100%, respectively (P = 0.005–0.03), which strongly correlated with in vitro lipolytic stimulation (r = 0.7–0.9). The antilipolytic effect of insulin in mature fat cells and the stimulated lipolytic effect in differentiated preadipocytes were unaltered in cachexia. Patients who lost weight due to other factors than cancer cachexia had no change in adipocyte lipolysis. In conclusion, adipocyte lipolysis is increased in cancer cachexia not due to nonepigenic factors or to weight loss per se, but most probably because of enhanced expression and function of adipocyte HSL. The selective inhibition of this enzyme may prevent fat loss in cancer patients. [Cancer Res 2007;67(11):5531–7]
- Published
- 2007
19. Pancreaticoduodenectomy for Peri-Ampullary Neoplasia Leads to Specific Micronutrient Deficiencies
- Author
-
F. Ruiz-Jasbon, Thomas Armstrong, Colin D. Johnson, F.W. Shek, Johan Permert, L. Strömmer, and Scott Harris
- Subjects
Male ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Peri ,Gastroenterology ,Pancreaticoduodenectomy ,Internal medicine ,medicine ,Humans ,Micronutrients ,Survivors ,Aged ,Aged, 80 and over ,Hepatology ,business.industry ,Avitaminosis ,Vitamins ,Middle Aged ,Micronutrient ,Trace Elements ,Surgery ,Pancreatic Neoplasms ,Female ,business - Abstract
After pancreaticoduodenectomy (PD) patients may be deficient in essential micronutrients. This study was designed to determine if this is a consequence of surgery.Long-term survivors (6 months) of PD for peri-ampullary neoplasia and healthy controls (patients' spouse/partner) were enrolled in the study. Specific clinical parameters were recorded, serum micronutrient levels were measured and subjects completed 7-day food diaries.Thirty-seven patients were studied, 25 with paired controls. All were well nourished, as defined by body mass index and food diary analysis. Patients with paired controls were representative of all patients studied. Patients had raised transferrin (median 2.60 vs. 2.16 g/l, p = 0.001) and low ferritin levels (34.9 vs. 119.0 g/l, p0.001) indicating relative iron deficiency. Patients also demonstrated lower levels of the anti-oxidants selenium (0.77 vs. 0.93 micromol/l, p0.001) and vitamin E (23.2 vs. 35.7 micromol/l, p0.001) with 57% of patients having frank selenium deficiencies. Patients had lower levels of vitamin D than controls (15.7 vs. 19.6 micromol/l, p = 0.001) and 30% of patients had a raised parathyroid hormone level, suggesting compensatory mechanisms operate to maintain normocalcaemia.Long-term survivors of PD are relatively deficient in several micronutrients compared to non-operated controls taking the same diet. We recommend that micronutrient status should be regularly checked in these patients and treated where necessary.
- Published
- 2007
20. Hypoxia Inducible Factor-1 Mediates Effects of Insulin on Pancreatic Cancer Cells and Disturbs Host Energy Homeostasis
- Author
-
Ralf Segersvärd, Karl-Gösta Sundqvist, Shu Shun Li, Jan Holgersson, L. Strömmer, Feng Wang, and Johan Permert
- Subjects
Vascular Endothelial Growth Factor A ,medicine.medical_specialty ,Pancreatic disease ,medicine.medical_treatment ,Mice, Nude ,Biology ,Pathology and Forensic Medicine ,Mice ,Paracrine signalling ,chemistry.chemical_compound ,Cell Line, Tumor ,Hexokinase ,Internal medicine ,Pancreatic cancer ,medicine ,Animals ,Homeostasis ,Humans ,Hypoglycemic Agents ,Insulin ,Cell Proliferation ,Hypoxia-Inducible Factor 1, alpha Subunit ,medicine.disease ,Cell Hypoxia ,Cell biology ,Pancreatic Neoplasms ,Vascular endothelial growth factor A ,medicine.anatomical_structure ,Endocrinology ,Gene Expression Regulation ,chemistry ,Pancreas ,Glycolysis ,Neoplasm Transplantation ,Regular Articles - Abstract
Intratumoral hypoxia and paracrine insulin stimulate the expression of hypoxia inducible factor-1alpha (HIF-1alpha) in pancreatic cancer cells. In the present studies, we investigated whether insulin-induced HIF-1alpha expression is a prerequisite for insulin to induce other trophic effects in MiaPaCa2 human pancreatic cancer cells and whether inhibition of HIF-1alpha expression would decrease tumor glycolysis and improve host energy homeostasis. We found that hypoxia was a prerequisite for induction of HIF-1alpha mRNA expression by insulin in MiaPaCa2 cells. Under hypoxic conditions, insulin stimulated glycolysis, cell proliferation, and the secretion of vascular endothelial growth factor in regular MiaPaCa2 cells but not in a MiaPaCa2 variant (si-MiaPaCa2) that expressed specific short interfering RNA for HIF-1alpha and therefore lacked HIF-1alpha protein. This suggests that HIF-1alpha expression is required for insulin to induce other trophic effects. When si-MiaPaCa2 cells were transplanted into the pancreas of athymic mice, they were less tumorigenic and expressed less hexokinase than regular MiaPaCa2 cells. Body weight gain was attenuated in mice hosting tumors composed of regular MiaPaCa2 but not si-MiaPaCa2 cells. These results suggest that an interaction between insulin and HIF-1alpha helps sustain pancreatic cancer cells and disturbs host energy homeostasis.
- Published
- 2007
21. Efficacy of systemic therapy in advanced pancreatic carcinoma
- Author
-
Pehr Lind, Anders Lideståhl, Johan Permert, Håkan Bylund, Nick Edsborg, and Stefan Linder
- Subjects
Oncology ,medicine.medical_specialty ,Systemic therapy ,Causes of cancer ,Pharmacotherapy ,Internal medicine ,Pancreatic cancer ,Antineoplastic Combined Chemotherapy Protocols ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Radical surgery ,business.industry ,Combination chemotherapy ,Hematology ,General Medicine ,medicine.disease ,Gemcitabine ,Surgery ,Pancreatic Neoplasms ,Clinical Trials, Phase III as Topic ,Localized disease ,Quality of Life ,business ,medicine.drug - Abstract
With a worldwide incidence of more than 200 000 cases and almost as many deaths, pancreatic carcinoma (PC) remains one of the leading causes of cancer deaths, especially in the Western world. Due to the late onset of symptoms, almost all patients suffer from disseminated disease at the time of diagnosis and only a minority will ever be candidates for radical surgery. Only about one tenth of the operated patients remain disease free. For these reasons, development of effective palliative systemic therapy is important. Almost a decade ago, gemcitabine replaced 5-Fu as the gold standard in systemic treatment of advanced PC. Since then, a number of trials have investigated the potential additional effect of several cytotoxic or targeted agents in combination with gemcitabine. As shown in this review, nearly all these trials have proved disappointing. This review provides an overview of the results of current phase III trials of gemcitabine based systemic therapy. Furthermore, we discuss the role of systemic therapy compared to BSC only and the potential future role of targeted therapies. Survival in patients with infiltrating ductal adenocarcinoma of the pancreas (PC) is limited [1]. The majority of patients have metastases or locally advanced disease at diagnosis rendering them unsuitable for potentially curative resections [2]. This fact, as well as the relative ineffectiveness of existing treatments for localized disease, implies that most patients will be considered for systemic therapy. For many years, 5-Fu was considered the most active chemotherapeutic agent for systemic treatment in patients with advanced PC. Currently, gemcitabine has taken the role as the drug of choice and it is, despite its limited activity, considered gold standard for the control arm in the evaluation of new therapies. This far, combination chemotherapy has not proven more efficacious than single drug therapy. This fact has increased the interest for alternative therapeutic strategies, e.g. targeted therapies. The relative inefficacy of systemic therapy has also raised the question whether patients with advanced PC still should be recommended best supportive care (BSC) only. An overview of systemic chemotherapy in pancreatic cancer of all stages was performed by the Swedish Council of Technology Assessment in Health Care (SBU) in 2001 [3]. Herein, we present an update of the current status on and the indication for systemic therapy for advanced PC.
- Published
- 2006
22. The risk of pancreatic cancer in patients with gastric or duodenal ulcer disease
- Author
-
Weimin Ye, Caroline Nordenvall, Johan Permert, Juhua Luo, Hans-Olov Adami, and Olof Nyrén
- Subjects
Male ,Cancer Research ,medicine.medical_specialty ,Pancreatic disease ,Atrophic gastritis ,medicine.medical_treatment ,Vagotomy ,Gastroenterology ,Helicobacter Infections ,Gastrectomy ,Risk Factors ,Internal medicine ,Pancreatic cancer ,Humans ,Medicine ,Stomach Ulcer ,Risk factor ,Aged ,Helicobacter pylori ,biology ,business.industry ,Incidence ,Retrospective cohort study ,Middle Aged ,medicine.disease ,biology.organism_classification ,digestive system diseases ,Pancreatic Neoplasms ,Oncology ,Duodenal Ulcer ,Female ,business - Abstract
Although Helicobacter pylori (H. pylori) seropositivity is linked to an excess risk of pancreatic cancer, the biologic mechanism is unknown. Gastric ulcer is primarily associated with corpus colonization of H. pylori, atrophic gastritis and formation of N-nitrosamines. Duodenal ulcer is a marker of antral colonization, hyperacidity and uninhibited secretin release. We estimated relative risks for pancreatic cancer among patients with gastric or duodenal ulcer, based on a register-based retrospective cohort study with 88,338 patients hospitalized for gastric ulcer and 70,516 patients for duodenal ulcer recorded in the Swedish Inpatient Register between 1965 and 2003. Following operation, the 14,887 patients who underwent gastric resection and 8,205 with vagotomy were analyzed separately. Multiple record-linkages allowed complete follow-up and identification of all incident cases of pancreatic cancer until December 31, 2003. Standardized incidence ratios (SIRs) estimated relative risks. During years 3-38 of follow-up, we observed a 20% excess risk (95% confidence interval [CI] 10-40%) for pancreatic cancer among unoperated gastric ulcer patients. The excess increased to 50% (95% CI 10-110%) 15 years after first hospitalization (p for trend = 0.03). SIR was 2.1 (95% CI 1.4-3.1) 20 years after gastric resection. Unoperated duodenal ulcer was not associated with pancreatic cancer risk, nor was vagotomy. Our results lend indirect support to the nitrosamine hypothesis, but not to the hyperacidity hypothesis in the etiology of pancreatic cancer.
- Published
- 2006
23. Meat, fish, poultry and egg consumption in relation to risk of pancreatic cancer: A prospective study
- Author
-
Johan Permert, Niclas Håkanson, Susanna C. Larsson, and Alicja Wolk
- Subjects
Cancer Research ,medicine.medical_specialty ,Meat ,Eggs ,Population ,Cohort Studies ,Internal medicine ,Environmental health ,Pancreatic cancer ,Odds Ratio ,medicine ,Humans ,Prospective Studies ,Registries ,Risk factor ,education ,Prospective cohort study ,education.field_of_study ,business.industry ,Hazard ratio ,Cancer ,Middle Aged ,medicine.disease ,Diet ,Pancreatic Neoplasms ,Endocrinology ,Oncology ,Red Meat Consumption ,Red meat ,Female ,business - Abstract
High meat consumption has been associated with increased risk of pancreatic cancer in several, although not all, case-control studies. However, prospective data on this relationship are sparse, and the results have been inconsistent. We prospectively evaluated meat, fish, poultry, and egg consumption in relation to pancreatic cancer incidence in a population-based cohort of 61,433 Swedish women. Diet was assessed with a food-frequency questionnaire at baseline (1987-1990) and again in 1997. Pancreatic cancers were ascertained through linkage to the Swedish Cancer Register. Cox proportional hazards models were used to estimate multivariate hazard ratios with 95% confidence intervals (CI). During the 941,218 person-years of follow-up, from 1987 through 2004, 172 incident cases of pancreatic cancer were diagnosed. Long-term red meat consumption (using data from both dietary questionnaires) was positively associated with risk of pancreatic cancer (p-trend = 0.01), whereas long-term poultry consumption was inversely (p-trend = 0.04) associated with risk. The multivariate hazard ratios for the highest versus the lowest category of consumption were 1.73 (95% CI = 0.99-2.98) for red meat and 0.44 (95% CI = 0.20-0.97) for poultry. There were no significant associations with processed meat, fish or egg consumption. Findings from this prospective study suggest that substituting poultry for red meat might reduce the risk of pancreatic cancer.
- Published
- 2006
24. Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts
- Author
-
Leif Bergkvist, I Näslund, Niclas Håkansson, Johan Permert, Susanna C. Larsson, and Alicja Wolk
- Subjects
Adult ,Male ,obesity ,Cancer Research ,medicine.medical_specialty ,Waist ,Epidemiology ,medicine.medical_treatment ,Abdominal Fat ,body mass index ,Rate ratio ,smoking ,Cohort Studies ,Diabetes Complications ,Sex Factors ,Risk Factors ,Internal medicine ,medicine ,Humans ,Risk factor ,Prospective cohort study ,Aged ,Aged, 80 and over ,Sweden ,anthropometry ,business.industry ,pancreatic neoplasms ,Middle Aged ,prospective studies ,smoking cessation ,Surgery ,Oncology ,diabetes mellitus ,Cohort ,Smoking cessation ,Female ,business ,Body mass index ,Cohort study - Abstract
We examined the associations of body mass index (BMI), waist circumference, a history of diabetes, and cigarette smoking with risk of pancreatic cancer among 37,147 women and 45,906 men followed up during 560,666 person-years in the Swedish Mammography Cohort and the Cohort of Swedish Men; 136 incident cases of pancreatic cancer were diagnosed. The multivariate rate ratio (RR) of pancreatic cancer for obese women and men (BMI > or =30 kg/m(2)) was 1.81 (95% CI: 1.04-3.15) compared to those with a BMI of 20-25 kg/m(2). For a difference of 20 cm (about two standard deviations) in waist circumference, the multivariate RRs were 1.32 (95% CI: 0.73-2.37) among women and 1.74 (95% CI: 1.00-3.01) among men. Pancreatic cancer risk was associated with history of diabetes (multivariate RR: 1.88; 95% CI: 1.09-3.26) and cigarette smoking (multivariate RR for current compared with never smokers: 3.06; 95% CI: 1.99-4.72). Current smokers of > or =40 pack-years had a five-fold elevated risk compared with never smokers. Risk among past smokers approached the RR for never smokers within 5-10 years following smoking cessation. Findings from this prospective study support positive relationships of overall obesity, abdominal adiposity, diabetes and smoking with risk of pancreatic cancer.
- Published
- 2005
25. Effects of isoflurane on prefrontal acetylcholine release and hypothalamic Fos response in young adult and aged rats
- Author
-
Takashi Yoshitake, Johan Permert, A. Jansson, Margery K. Herrington, B. Hagman, Jan Kehr, and K. Olin
- Subjects
Male ,Senescence ,medicine.medical_specialty ,Microdialysis ,Central nervous system ,Hypothalamus ,Prefrontal Cortex ,chemistry.chemical_compound ,Developmental Neuroscience ,Internal medicine ,medicine ,Animals ,Rats, Wistar ,Young adult ,Neurotransmitter ,Isoflurane ,business.industry ,Age Factors ,Immunohistochemistry ,Acetylcholine ,Rats ,Oncogene Proteins v-fos ,Endocrinology ,medicine.anatomical_structure ,nervous system ,Neurology ,chemistry ,Anesthesia ,Anesthetics, Inhalation ,business ,Nucleus ,medicine.drug - Abstract
This experiment investigated the influence of age on prefrontal acetylcholine (ACh) release and Fos response in the hypothalamic paraventricular nucleus and the nucleus tractus solitarius (NTS) of rats following isoflurane anesthesia. It is known that isoflurane decreases acetylcholine release in most brain regions. In the present study, we found that the level of prefrontal acetylcholine was significantly lower in 28-month-old rats (14% of baseline) than in 3-month-old rats (38% of baseline) during 2 h of isoflurane anesthesia (P < 0.05). The old rat group showed significantly greater Fos induction in the paraventricular nucleus compared to the young adult rat group (P < 0.05), indicating that the old rats were subjected to stress. No difference in Fos response was noted in the nucleus tractus solitarius. The old rats displayed a significant increase in feeding behavior during the 3-h recovery period (P < 0.05), but there was no difference in overall acetylcholine levels. Taken together, these findings suggest that isoflurane anesthesia influences old rats more profoundly than young adult rats with regard to reductions in acetylcholine release and stress responses. This may have implications for understanding the development of postoperative delirium in aged patients.
- Published
- 2004
26. Amylin receptor blockade stimulates food intake in rats
- Author
-
Courtney S. Schaffert, Roger D. Reidelberger, Johan Permert, D. David Smith, Alvin C. Haver, and Urban Arnelo
- Subjects
Amyloid ,medicine.medical_specialty ,Food intake ,Receptors, Peptide ,Physiology ,medicine.drug_class ,Central nervous system ,Amylin ,Anorexia ,Rats, Sprague-Dawley ,Eating ,Enteral Nutrition ,Physiology (medical) ,Internal medicine ,medicine ,Animals ,Intubation, Gastrointestinal ,Food, Formulated ,Chemistry ,digestive, oral, and skin physiology ,Antagonist ,Receptor antagonist ,Peptide Fragments ,Receptors, Islet Amyloid Polypeptide ,Islet Amyloid Polypeptide ,Rats ,Endocrinology ,medicine.anatomical_structure ,Injections, Intravenous ,medicine.symptom ,Peptides ,Hormone - Abstract
Amylin is postulated to act as a hormonal signal from the pancreas to the brain to inhibit food intake and regulate energy reserves. Amylin potently reduces food intake, body weight, and adiposity when administered systemically or into the brain. Whether selective blockade of endogenous amylin action increases food intake and adiposity remains to be clearly established. In the present study, the amylin receptor antagonist acetyl-[Asn30, Tyr32] sCT-( 8 – 32 ) (AC187) was used to assess whether action of endogenous amylin is essential for normal satiation to occur. Non-food-deprived rats received a 3- to 4-h intravenous infusion of AC187 (60–2,000 pmol·kg−1·min−1), either alone or coadministered with a 3-h intravenous infusion of amylin (2.5 or 5 pmol·kg−1·min−1) or a 2-h intragastric infusion of an elemental liquid diet (4 kcal/h). Infusions began just before dark onset. Food intake and meal patterns during the first 4 h of the dark period were determined from continuous computer recordings of changes in food bowl weight. Amylin inhibited food intake by ∼50%, and AC187 attenuated this response by ∼50%. AC187 dose-dependently stimulated food intake (maximal increases from 76 to 171%), whether administered alone or with an intragastric infusion of liquid diet. Amylin reduced mean meal size and meal frequency, AC187 attenuated these responses, and AC187 administration alone increased mean meal size and meal frequency. These results support the hypothesis that endogenous amylin plays an essential role in reducing meal size and increasing the postmeal interval of satiety.
- Published
- 2004
27. Impact of chronic and acute high‐fat feeding on acute experimental pancreatitis complicated by endotoxinaemia
- Author
-
M. Sylván, Johan Permert, Marko Lempinen, Ralf Segersvärd, and Larsson Jo
- Subjects
Lipopolysaccharides ,Male ,medicine.medical_specialty ,Pancreatic disease ,Diet therapy ,Internal medicine ,medicine ,Animals ,Obesity ,Survival rate ,Dose-Response Relationship, Drug ,Pancreatitis, Acute Necrotizing ,Bile duct ,business.industry ,Gastroenterology ,medicine.disease ,Dietary Fats ,Diet ,Rats ,Rats, Zucker ,Dose–response relationship ,medicine.anatomical_structure ,Endocrinology ,Models, Animal ,Acute pancreatitis ,Pancreatitis ,Steatosis ,business - Abstract
Obesity is associated with increased severity in patients with acute pancreatitis (AP). The underlying mechanisms are unknown. Genetically obese rats exhibit decreased survival rate in experimental AP, but the clinical relevance of this model of obesity may be questioned. It is proposed that development of organ failure in AP occurs in two stages: initial priming of leucocytes followed by a second inflammatory attack. The aim was to evaluate the impact of diet-induced obesity on outcome in a 'two-hit' model of AP.Lipopolysaccharide (LPS) was injected i.p. 3 h after retrograde bile duct infusion of sodium taurocholate in rats. Three experiments were done: 1) an LPS dose-response experiment, 2) chronic high-fat feeding (HF) for 16 weeks, and 3) acute HF for 10 days. Control rats received normal chow. Obesity, morphology and survival rate were assessed.LPS dose-dependently decreased survival rate and increased morphological severity. HF increased weight, intra-abdominal and liver fat. Only acute HF induced hyperlipidaemia. In AP, acute obese rats exhibited less pancreatic inflammation, but total histological severity between groups was not different. In the chronic experiment only obese animals succumbed before 24 h of pancreatitis, but 72-h survival rate was not statistically different in either high-fat experiment.An addition of LPS to AP decreases survival rate and intensifies the peri-pancreatic processes. Despite significant obesity, neither hyperlipidaemia nor increased intra-abdominal or hepatic fat influenced local pancreatic injury or survival negatively. The amount of fat per se seems not to be responsible for the deleterious influence of obesity on acute pancreatitis.
- Published
- 2004
28. Impaired Insulin Action on Phosphatidylinositol 3-Kinase Activity and Glucose Transport in Skeletal Muscle of Pancreatic Cancer Patients
- Author
-
Markus W. Büchler, Margery K. Herrington, Feng Wang, Helmut Friess, Juleen R. Zierath, Jörgen Larsson, Harriet Wallberg-Henriksson, Bengt Isaksson, Lisa Strömmer, and Johan Permert
- Subjects
Male ,medicine.medical_specialty ,Monosaccharide Transport Proteins ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Blotting, Western ,Muscle Proteins ,In Vitro Techniques ,Phosphatidylinositol 3-Kinases ,Endocrinology ,Insulin resistance ,Internal medicine ,Internal Medicine ,medicine ,Humans ,Insulin ,Kinase activity ,Muscle, Skeletal ,Pancreatic hormone ,Aged ,Glucose tolerance test ,Glucose Transporter Type 4 ,Hepatology ,biology ,medicine.diagnostic_test ,Glucose transporter ,Biological Transport ,Glucose Tolerance Test ,Middle Aged ,medicine.disease ,Pancreatic Neoplasms ,Glucose ,Basal (medicine) ,biology.protein ,3-O-Methylglucose ,Female ,GLUT4 - Abstract
Introduction: Glucose intolerance or overt diabetes occurs in 80% of patients with pancreatic cancer (PC). This associated metabolic disorder includes peripheral insulin resistance, which may be caused by factors produced by the PC. The mechanism underlying PC-associated insulin resistance has not been clearly defined. Aim: To characterize basal and insulin-stimulated glucose transport, phosphatidylinositol (PI) 3-kinase activity, and glucose transporter 4 (GLUT4) in skeletal muscles of PC patients. Methodology: Skeletal muscle samples were obtained from the abdominal wall of 17 PC patients during surgery. Control muscles were sampled in the same way from 11 donors undergoing abdominal surgery for benign diseases. PI 3-kinase activity, glucose transport, and GLUT4 were assessed in vitro in these muscles. Results: In the presence of physiologic concentrations of insulin, glucose transport and PI 3-kinase activity were significantly decreased in the PC group compared with controls. At supraphysiologic insulin concentrations, glucose transport was significantly decreased but PI 3-kinase activity was normalized. In the absence of insulin, these parameters were not significantly different between PC and control groups. Muscle GLUT4 contents were similar between PC and control groups. Conclusion: Defects in insulin-mediated PI 3-kinase activity and glucose transport contribute to the insulin resistance in patients with PC.
- Published
- 2003
29. Early impairment of insulin secretion in rats after surgical trauma
- Author
-
Lisa Strömmer, Malin Wickbom, Johan Permert, Claes-Göran Östenson, Urban Arnelo, Feng Wang, and Margery K. Herrington
- Subjects
Male ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,In Vitro Techniques ,Arginine ,Islets of Langerhans ,chemistry.chemical_compound ,Endocrinology ,Insulin resistance ,Corticosterone ,Internal medicine ,Insulin Secretion ,Intestine, Small ,Animals ,Insulin ,Medicine ,Glucose homeostasis ,Rats, Wistar ,Digestive System Surgical Procedures ,Pancreatic hormone ,Glucose tolerance test ,medicine.diagnostic_test ,business.industry ,Pancreatic islets ,General Medicine ,Glucose Tolerance Test ,medicine.disease ,Pathophysiology ,Rats ,medicine.anatomical_structure ,chemistry ,business - Abstract
OBJECTIVE: Hyperglycaemia associated with insulin resistance is common after trauma and surgical procedures. Both reduced insulin sensitivity and altered insulin secretion may contribute to the impaired glucose homeostasis. We have demonstrated that skeletal muscle insulin resistance is present 2 h after small intestinal resection in rats. In this study, the aim was to investigate insulin secretion in the same experimental model. DESIGN: Small intestinal resection (5 cm) was performed in adult rats. The control animals underwent anaesthesia only. METHODS: The intravenous glucose tolerance test (IVGTT), the hyperglycaemic clamp and in vitro studies in isolated pancreatic islets were performed after surgery. Concentrations of blood glucose, plasma insulin, corticosterone and interleukin-6 (IL-6) were determined 0-5 h postoperatively. RESULTS: The insulin response in the IVGTT was attenuated 2 h (P
- Published
- 2002
30. Obesity Increases the Severity of Acute Experimental Pancreatitis in the Rat
- Author
-
Johan Permert, Jörgen Larsson, Ralf Segersvärd, M Herrington, and M. Sylván
- Subjects
Male ,Taurocholic Acid ,medicine.medical_specialty ,Fatal outcome ,Pancreatic disease ,Pancreatitis, Acute Necrotizing ,business.industry ,Sodium taurocholate ,Gastroenterology ,Nutritional status ,medicine.disease ,Dietary Fats ,Obesity ,Rats ,Rats, Zucker ,Endocrinology ,Internal medicine ,medicine ,Animals ,Acute pancreatitis ,Pancreatitis ,In patient ,business - Abstract
Studies in patients with acute pancreatitis have shown a correlation between obesity and serious complications or a fatal outcome. However, the mechanisms by which obesity aggravates acute pancreatitis are not known. In the present study we used the sodium taurocholate model of pancreatitis to examine the effect of obesity on severity and outcome in acute experimental pancreatitis (AEP).AEP was induced at two degrees of severity by retrograde infusion of sodium taurocholate (0.2 ml x 3% or 0.4 ml x 3.5%) into the pancreatic duct of rats with obesity induced by high-fat diet, genetically obese (GO) rats or lean control rats. Surviving animals were sacrificed 72 h after induction of pancreatitis.In the low-dose experiment, there were no significant differences in pancreatic histology or survival rate between the groups. In the high-dose experiment, the GO rats had a significantly lower 72-h survival rate than the high-fat obese (HFO) or lean control (LC) groups (GO 25% versus HFO 73%, P0.05; GO 25% versus LC 100%, P0.001). Survival rates in the high-dose experiment correlated strongly with basal liver fat content (R2 = 0.86). Pancreatic histology showed significantly more fat necrosis and a higher total pathological mean score in the HFO rats than in the LC animals (both P0.05).Obesity had a negative influence on the outcome of necrotizing pancreatitis that was related to the magnitude of the pancreatic insult. The sodium taurocholate model in obese rats would be useful for future mechanistic studies of the effect of obesity on pancreatitis.
- Published
- 2001
31. Effect of carbohydrate feeding on insulin action in skeletal muscle after surgical trauma in the rat
- Author
-
Bengt Isaksson, Margery K. Herrington, Malin Wickbom, Claes-Göran Östenson, Urban Arnelo, Johan Permert, and Lisa Strömmer
- Subjects
Blood Glucose ,Male ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,Glucose uptake ,medicine.medical_treatment ,Biology ,Glucagon ,Insulin resistance ,Internal medicine ,Preoperative Care ,Dietary Carbohydrates ,medicine ,Animals ,Insulin ,Rats, Wistar ,Muscle, Skeletal ,Pancreatic hormone ,Postoperative Care ,Nutrition and Dietetics ,Glucose transporter ,Skeletal muscle ,Biological Transport ,medicine.disease ,Rats ,Disease Models, Animal ,Glucose ,medicine.anatomical_structure ,Endocrinology ,Insulin Resistance ,Hormone - Abstract
Metabolic stress after surgery is associated with peripheral insulin resistance. Recent studies have suggested that preoperative glucose can ameliorate postoperative decreases in insulin-stimulated glucose disposal. In the present experiments, we used a bowel-resection model of surgical trauma to test the hypothesis that elevations of serum insulin induced by preoperative oral glucose or ad libitum feeding affects postoperative insulin-stimulated glucose uptake in skeletal muscle. Insulin-stimulated glucose transport was measured in vitro in soleus muscles after surgical trauma in fasted rats given oral glucose or water before surgery. Insulin-stimulated glucose transport was also assessed in vitro in fasted or fed traumatized rats and non-traumatized control animals. In addition, stress hormones (glucagon, corticosterone, and adrenaline) were measured before and after surgical trauma in fasted rats and rats fed ad libitum. In vitro skeletal-muscle insulin sensitivity and responsiveness were reduced postoperatively in fasted animals that received oral glucose loads before bowel resections and in rats fed ad libitum or fasted before surgery versus non-traumatized rats (all P < 0.05). Stress-hormone concentrations after trauma did not differ between fed and fasted animals. In the current study, insulin sensitivity and responsiveness were reduced in isolated skeletal muscles after bowel resection, but neither preoperative glucose supplementation nor free intake of mixed nutrients ameliorated the development of postoperative insulin resistance.
- Published
- 2001
32. Effects of long-term infusion of anorexic concentrations of islet amyloid polypeptide on neurotransmitters and neuropeptides in rat brain
- Author
-
Margery K. Herrington, Johan Permert, Roger D. Reidelberger, Xian-Zhong Ding, Lisa Strömmer, Elvar Theodorsson, Urban Arnelo, Jörgen Larsson, Thomas E. Adrian, and Jan Marcusson
- Subjects
Blood Glucose ,Male ,Amyloid ,Serotonin ,endocrine system ,medicine.medical_specialty ,Dopamine ,Central nervous system ,Neuropeptide ,Amylin ,Anorexia ,Methoxyhydroxyphenylglycol ,Norepinephrine ,chemistry.chemical_compound ,Internal medicine ,medicine ,Animals ,Insulin ,Biogenic Monoamines ,Infusions, Parenteral ,Neuropeptide Y ,Rats, Wistar ,Neurotransmitter ,Molecular Biology ,Chromatography, High Pressure Liquid ,Neurotensin ,geography ,geography.geographical_feature_category ,Dose-Response Relationship, Drug ,General Neuroscience ,Neuropeptides ,Brain ,Homovanillic Acid ,Hydroxyindoleacetic Acid ,Islet ,Rat brain ,Islet Amyloid Polypeptide ,Rats ,Endocrinology ,medicine.anatomical_structure ,chemistry ,3,4-Dihydroxyphenylacetic Acid ,Neurology (clinical) ,medicine.symptom ,Cholecystokinin ,Developmental Biology - Abstract
Islet amyloid polypeptide (IAPP or amylin) potently reduces food intake in rats at or near physiological concentrations. Although the mechanisms of action of IAPP are not understood, the brain is a suggested site. Changes in hypothalamic and striatal neurotransmission have been reported following acute systemic administration of a pharmacological concentration of IAPP. In the current study, we evaluated the effects of chronic administration of low doses of IAPP on satiety-related neurotransmitters and neuropeptides in the hypothalamus, hippocampus, striatum, left cortex, and right cortex of the rat. Doses of 0, 5 and 25 pmol IAPP/kg-min were administered subcutaneously for 2 or 5 days. Food intake was reduced by 27 and 44% (both P0.001) for the 5 and 25 pmol/kg-min groups, respectively, in the 2-day experiment and was decreased by 14% (P0.01) and 24% (P0.001), respectively, in the 5-day experiment. Body weight was significantly decreased in a dose-dependent fashion. In the 2-day experiment, norepinephrine increased in the hypothalamus in the 5 pmol IAPP/kg-min group, and neurotensin increased in the hippocampus in the 25 pmol/kg-min rats (both P0.05). In the 5-day, 5 pmol/kg-min rats, 5-hydroxyindoleacetic acid (5-HIAA) increased in the hypothalmus and cholecystokinin (CCK) increased in the striatum (both P0.05). In the 5-day, 25 pmol/kg-min group, neuropeptide Y (NPY) increased in the hypothalamus (P0.01) and CCK increased in the hypothalmus and striatum (both P0.05). The present study confirms that IAPP is a potent anorectic peptide at low doses and suggests that IAPP not only affects classical neurotransmitters in the brain but also alters concentrations of neuropeptides known to be involved in food intake.
- Published
- 2000
33. Bolus ornithine and arginine-ketoglutarate supplementation in distal intestine after 65% resection in rats
- Author
-
Jörgen Larsson, Mikael Wirén, Johan Permert, and H. Yang
- Subjects
medicine.medical_specialty ,Nutrition and Dietetics ,Arginine ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Ornithine ,Biology ,Short bowel syndrome ,medicine.disease ,Enteral administration ,Gastroenterology ,Small intestine ,chemistry.chemical_compound ,Endocrinology ,medicine.anatomical_structure ,Bolus (medicine) ,chemistry ,Intestinal mucosa ,Internal medicine ,medicine ,Saline - Abstract
Introduction: Enteral feeding has been reported to increase intestinal mucosa proliferation after resection. Dietary components influence the intestinal adaptive response. The purpose of this study was to evaluate the effect of ornithine- (OKG) or arginine-ketoglutarate (AKG) bolus supplementation on intestinal postresectional adaptation in the rat. Methods: Male Wistar rats underwent 65% small-bowel resection and received either OKG 3 g/kg/day, isonitrogenous AKG or saline by gavage once daily. The animals had free access to rat chow. Sampling was done 10 days after resection. Fed animals without surgery or specific treatment served as controls. Results: Mucosal wet weight, DNA, RNA, protein content and sucrose activity of the mucosa, as well as villus height were significantly increased in all resected animals compared to controls. No significant differences in body weight or intestinal adaptation could be found between the three dietary groups. Conclusion: Postoperative enteral bolus feeding supplemented with OKG or AKG did not significantly enhance the adaptation of the remnant small bowel 10 days after massive intestinal resection when rats had free access to rat chow. © 2000 Elsevier Science Inc.
- Published
- 2000
34. Bidirectional supply of glutamine maintains enterocyte ATP content in the in vitro Ussing chamber model
- Author
-
Jörgen Larsson, Johan D. Söderholm, Johan Permert, H. Yang, Mikael Wirén, and Johan Lindgren
- Subjects
Male ,medicine.medical_specialty ,Time Factors ,Enterocyte ,Glutamine ,Biology ,Enteral administration ,Jejunum ,Adenosine Triphosphate ,Intestinal mucosa ,Internal medicine ,medicine ,Animals ,Intestinal Mucosa ,Edetic Acid ,Chelating Agents ,Ussing chamber ,Temperature ,Gastroenterology ,Metabolism ,Rats ,Electrophysiology ,Enterocytes ,medicine.anatomical_structure ,Endocrinology ,Biochemistry ,Isotonic Solutions ,Food Deprivation ,Energy source - Abstract
Glutamine is the principal energy source for enterocytes, but it is not known whether parenteral or enteral supplementation is most ben- eficial to gut integrity. The aim of this study was to evaluate the effects of glutamine in uni- or bidirectional supply on the viability of intestinal mucosa of starved rats during incu- bation in Ussing chambers. Seg- ments of jejunum from rats starved for 48 h were randomly mounted in Ussing chambers with three nutrient solutions: Krebs buffer without glu- tamine; 6 mM glutamine added to the mucosal side; 6 mM glutamine added to the mucosal side and 0.6 mM glutamine to the serosal side. ATP content of the mucosa, electrophysiology, and 51 Cr-ethyl- enediaminetetraacetate (EDTA) per- meability were studied during 180 min of incubation. The addition of glutamine to both sides of the stripped mucosa improved ATP lev- els compared to the Krebs solution (P
- Published
- 2000
35. Physiological Concentrations of Insulin Augment Pancreatic Cancer Cell Proliferation and Glucose Utilization By Activating MAP Kinase, PI3 Kinase and Enhancing GLUT-1 Expression
- Author
-
Thomas E. Adrian, Leon Murphy, Drew M. Fehsenfeld, Xian-Zhong Ding, and Johan Permert
- Subjects
medicine.medical_specialty ,Pancreatic disease ,Monosaccharide Transport Proteins ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Glucose uptake ,Phosphatidylinositol 3-Kinases ,Endocrinology ,Internal medicine ,Tumor Cells, Cultured ,Internal Medicine ,medicine ,Humans ,Insulin ,Enzyme Inhibitors ,Pancreatic hormone ,Phosphoinositide-3 Kinase Inhibitors ,Flavonoids ,Glucose Transporter Type 1 ,Hepatology ,biology ,Glucose transporter ,DNA, Neoplasm ,Glucagon ,medicine.disease ,Insulin oscillation ,Androstadienes ,Enzyme Activation ,Pancreatic Neoplasms ,Insulin receptor ,Glucose ,medicine.anatomical_structure ,biology.protein ,Mitogen-Activated Protein Kinases ,Somatostatin ,Wortmannin ,Pancreas ,Protein Kinases ,Cell Division - Abstract
Pancreatic carcinoma is characterized by poor prognosis and lack of response to conventional therapy for reasons that are not clear. Because of the structural relationship between the exocrine and endocrine pancreas and high concentrations of islet hormones bathing pancreatic tissue, we hypothesized that pancreatic cancer cell proliferation and glucose utilization are regulated by pancreatic islet hormones, particularly insulin. Based on this, the effect of islet hormones on pancreatic cancer cells in vitro was investigated. Five pancreatic cancer cell lines, CD11, CD18, HPAF, PANC-1, and MiaPaCa2 were used to investigate the effect of islet hormones on cell proliferation, glucose utilization, and GLUT-1 expression. Insulin, but not somatostatin and glucagon, induced pancreatic cancer cell growth in a concentration- and time-dependent manner. At concentrations within the range of those in the intrapancreatic vasculature, insulin (10(-10)-10(-8) mol/L) markedly increased [3H]-thymidine incorporation. Insulin significantly enhanced glucose utilization of pancreatic cancer cells before it enhanced cell proliferation. The MAPK kinase inhibitor PD 098059 abolished insulin-stimulated DNA synthesis and partially reduced insulin-stimulated glucose uptake. In contrast, the PI3 kinase inhibitor wortmannin substantially inhibited insulin-induced glucose uptake and partially blocked thymidine incorporation. Furthermore, after 24-hour treatment with insulin, GLUT-I expression in pancreatic cancer cells was markedly increased, indicating that insulin enhances glucose utilization partly through increasing glucose transport. These findings suggest that insulin stimulates proliferation and glucose utilization in pancreatic cancer cells by two distinct pathways. Insulin augments DNA synthesis mainly by MAP kinase activation and glucose uptake mainly by PI3 kinase activation and enhancement of GLUT-I expression. High intrapancreatic concentrations of insulin are likely to play an important role in stimulating pancreatic cancer growth indirectly by increasing substrate availability as well as by direct action as a trophic factor.
- Published
- 2000
36. The Intracellular Mechanism of Insulin Resistance in Pancreatic Cancer Patients1
- Author
-
Lisa Strömmer, Jörgen Larsson, Joseph A. Knezetic, Thomas E. Adrian, Johan Permert, and Jian Liu
- Subjects
medicine.medical_specialty ,Pancreatic disease ,biology ,Glycogen ,business.industry ,Endocrinology, Diabetes and Metabolism ,Biochemistry (medical) ,Clinical Biochemistry ,medicine.disease ,Biochemistry ,chemistry.chemical_compound ,Glycogen phosphorylase ,Insulin receptor ,Endocrinology ,medicine.anatomical_structure ,chemistry ,Pancreatic cancer ,Internal medicine ,biology.protein ,medicine ,Glycogen synthase ,Pancreas ,business ,Pancreatic hormone - Abstract
The diabetes that frequently occurs in pancreatic cancer patients is characterized by profound peripheral insulin resistance. The intracellular mechanism of this insulin resistance was investigated in skeletal muscle biopsies from pancreatic cancer patients with or without diabetes and control subjects. Insulin receptor (IR) binding, tyrosine kinase activity, IR messenger RNA (mRNA), IR substrate-1 content, GLUT-4, and GLUT-4 mRNA content were all normal in pancreatic cancer patients. In contrast, multiple defects in glycogen synthesis were found in pancreatic cancer patients, especially in those with diabetes. Glycogen synthase I activity, total activity, and mRNA levels were significantly decreased in pancreatic cancer patients compared with controls. The fractional velocity of glycogen synthase was decreased only in the diabetic pancreatic cancer group. Glycogen phosphorylase a and b activities were increased in diabetic pancreatic cancer patients, but glycogen phosphorylase mRNA levels were not significantly different. The insulin resistance associated with pancreatic cancer is associated with a post-IR defect, which impairs skeletal muscle glycogen synthesis and glycogen storage.
- Published
- 2000
37. Early changes in islet hormone secretion in the hamster pancreatic cancer model
- Author
-
Margery K. Herrington, Johan Permert, Parviz M. Pour, Katherine Kazakoff, and Thomas E. Adrian
- Subjects
endocrine system ,medicine.medical_specialty ,geography ,geography.geographical_feature_category ,Pancreatic disease ,Health, Toxicology and Mutagenesis ,medicine.medical_treatment ,Amylin ,Biology ,Toxicology ,medicine.disease ,Islet ,Endocrinology ,medicine.anatomical_structure ,Oncology ,Internal medicine ,Pancreatic cancer ,Pancreatic juice ,Pancreatectomy ,Genetics ,medicine ,Pancreas ,Genetics (clinical) ,Pancreatic hormone - Abstract
The diabetic state that is seen at a high frequency in association with pancreatic cancer is characterized by elevated plasma levels of several islet hormones and by marked insulin resistance. Both the diabetic state and insulin sensitivity improve after tumor removal by sub-total pancreatectomy. Impaired glucose tolerance has also been found in the hamster pancreatic cancer model, but conflicting data regarding islet function have been reported. In order to further investigate islet function and secretion during early development of pancreatic cancer, we measured the concentrations of insulin, glucagon, somatostatin, and islet amyloid polypeptide (IAPP) in plasma, pancreatic tissue, and secretin-stimulated pancreatic juice at 12 and 27 weeks after the ductal-cell-specific carcinogen, BOP had been used to induce tumors in Syrian golden hamsters. At 12 weeks after BOP, plasma glucagon levels were significantly increased. An exaggerated plasma-glucose response and concomitant hyperinsulinemia were observed at 27 but not 12 weeks after BOP. Plasma IAPP concentrations, but not glucagon or somatostatin, were elevated at 27 weeks. Tissue concentrations of IAPP were substantially reduced in BOP-treated hamsters at 27 weeks. No differences in hormone concentrations were seen in pancreatic juice from the two groups at either of the two time points investigated. The study showed that islet hormone changes accompany the early development of pancreatic tumors in the hamster pancreatic model. The hormone changes and apparent insulin resistance resemble the metabolic changes found in humans with pancreatic cancer.
- Published
- 2000
38. No Effect of Bolus Glutamine Supplementation on the Postresectional Adaptation of Small Bowel Mucosa in Rats Receiving Chow ad libitum
- Author
-
Ylva Braaf, Mikael Wirén, Jörgen Larsson, H. Yang, and Johan Permert
- Subjects
Male ,Short Bowel Syndrome ,medicine.medical_specialty ,Glutamine ,Enteral administration ,Gastroenterology ,Resection ,Random Allocation ,Enteral Nutrition ,Intestinal mucosa ,Internal medicine ,medicine ,Animals ,Postoperative Period ,Intestinal Mucosa ,Rats, Wistar ,business.industry ,Short bowel syndrome ,medicine.disease ,Adaptation, Physiological ,Rats ,Evaluation Studies as Topic ,Dietary Supplements ,Glutamine supplementation ,Surgery ,Bolus (digestion) ,business - Abstract
Objective: Early postoperative enteral feeding has been reported to stimulate intestinal mucosa proliferation. Dietary components influence the intestinal adaptive response after resection and glutamine is a preferential nutrient to enterocytes. The purpose of this study was to evaluate the effects of bolus glutamine supplementation on intestinal adaptation. Methods: Male Wistar rats underwent a 65% small bowel resection. The rats were divided into three groups receiving glutamine 2 g/kg/day, isonitrogenous glycine or saline by gavage for 10 days. All the rats were provided with ordinary rat chow ad libitum. Sampling was done 10 days after resection. Animals fed ordinary rat chow without surgery or specific treatment served as control. Results: Mucosal wet weight, DNA, RNA, protein contents and sucrose activity, as well as villus height increased in the ileal remnant. No significant differences in any of these parameters or body weight could be found between the three groups. Conclusion: Postoperative enteral bolus glutamine supplementation at a dose of 2 g/kg b.w. did not enhance the adaptation of the residual intestine 10 days after massive intestinal resection in the rat.
- Published
- 2000
39. Whole-Protein-Based Enteral Formula Stimulates Intestinal Ornithine Decarboxylase Activity More Than Single Amino Acids but Does Not Affect Mucosal Adenosine Triphosphate Content in Early Postsurgical Refeeding
- Author
-
Mikael Wirén, Jörgen Larsson, Johan Permert, and H. Yang
- Subjects
Male ,Ornithine ,medicine.medical_specialty ,Arginine ,030309 nutrition & dietetics ,Glutamine ,Glycine ,Medicine (miscellaneous) ,Complete protein ,Biology ,Ornithine Decarboxylase ,Enteral administration ,Ornithine decarboxylase ,03 medical and health sciences ,chemistry.chemical_compound ,Adenosine Triphosphate ,Enteral Nutrition ,0302 clinical medicine ,Adenine nucleotide ,Internal medicine ,medicine ,Animals ,Postoperative Period ,Amino Acids ,Intestinal Mucosa ,Rats, Wistar ,Food, Formulated ,0303 health sciences ,Nutrition and Dietetics ,Rats ,Jejunum ,Standard enteral formula ,Endocrinology ,chemistry ,Ketoglutaric Acids ,030211 gastroenterology & hepatology ,Energy Metabolism - Abstract
BACKGROUND To restore intestinal integrity after starvation and trauma, luminal nutrients are essential. Specific nutrients such as glutamine support mucosal proliferation and energy metabolism. The aim of this study was to compare effects of enteral formula vs specific amino acids on ornithine decarboxylase (ODC) activity and adenine nucleotide metabolism in jejunal mucosa. METHODS Male Wistar rats (240 to 280 g) were starved for 48 hours and subjected to intestinal transection, gastrotomy, and jejunal instillation of 5mL nutrient solution. In the first experiment, standard enteral formula (EF) was compared with isonitrogenous formula supplemented with the glutamine precursor, alpha-ketoglutarate (alpha-KG). In a second experiment, 2% glutamine was compared with isonitrogenous ornithine alpha-KG, arginine alpha-KG, glycine and diluted standard enteral formula (EF), or saline. The ODC activity, adenosine triphosphates (ATP), and RNA and protein in the jejunal mucosa were analyzed 2 hours after surgery. RESULTS The ODC peak in jejunal mucosa in animals treated with EF was higher than when supplemented with alpha-KG (p < .05). Compared with specific amino compounds, EF resulted in a significantly higher ODC peak and no differences were seen between the different specific amino acids. Differences seen in ATP or energy charge between the groups were not significant. CONCLUSIONS Immediate postoperative enteral feeding by standard EF results in rapid increase of ODC activity. This response was attenuated when the enteral nutrition was supplemented with alpha-KG and was absent when isonitrogenous single amino acids were administered. We found no significant effects on ATP content in the small bowel mucosa by supplementing the diet with alpha-KG.
- Published
- 1999
40. Islet amyloid polypeptide tonally inhibits β-, α-, and δ-cell secretion in isolated rat pancreatic islets
- Author
-
Feng Wang, Thomas Gasslander, Johan Permert, Xian-Zhong Ding, Thomas E. Adrian, and Gunilla T. Westermark
- Subjects
Male ,Amyloid ,endocrine system ,medicine.medical_specialty ,Physiology ,Endocrinology, Diabetes and Metabolism ,Amylin ,In Vitro Techniques ,Glucagon ,Rats, Sprague-Dawley ,Islets of Langerhans ,Paracrine signalling ,Physiology (medical) ,Internal medicine ,Insulin Secretion ,medicine ,Animals ,Insulin ,Secretion ,Pancreatic hormone ,geography ,geography.geographical_feature_category ,Chemistry ,Immune Sera ,Pancreatic islets ,Islet ,Peptide Fragments ,Islet Amyloid Polypeptide ,Rats ,Endocrinology ,medicine.anatomical_structure ,Somatostatin ,hormones, hormone substitutes, and hormone antagonists - Abstract
Islet amyloid polypeptide (IAPP, or amylin) is produced in pancreatic β-cells. The intraislet significance of IAPP is still uncertain. In the present study, paracrine effects of endogenous IAPP and somatostatin were investigated in isolated rat pancreatic islets. The intraislet IAPP activity was inhibited with an IAPP antiserum or a specific antagonist [IAPP-(8—37)]. Somatostatin activity was inhibited by immunoneutralization. Basal insulin and glucagon secretion were not affected by the somatostatin and/or IAPP blockade. Arginine-stimulated insulin and glucagon secretion were dose dependently increased by IAPP antiserum, IAPP-(8—37), and somatostatin antiserum, respectively. Arginine-stimulated somatostatin secretion was dose dependently potentiated by IAPP antiserum. Insulin secretion induced by 16.7 mM glucose was enhanced by IAPP antiserum and IAPP-(8—37), respectively. A combination of somatostatin antiserum with IAPP antiserum or IAPP-(8—37) further enhanced the arginine-stimulated insulin and glucagon secretion compared with effects when the blocking reagents were used individually. These results indicate that endogenously produced IAPP tonally inhibits stimulated insulin, glucagon, and somatostatin secretion. Furthermore, the paracrine effects of IAPP and somatostatin are additive.
- Published
- 1999
41. Early Gastrointestinal Regulatory Peptide Response to Intestinal Resection in the Rat Is Stimulated by Enteral Glutamine Supplementation
- Author
-
Jörgen Larsson, Thomas E. Adrian, P. Staab, Mikael Wirén, Urban Arnelo, and Johan Permert
- Subjects
Male ,medicine.medical_specialty ,Glutamine ,Glucagon-Like Peptides ,Enteroglucagon ,Regulatory peptide ,Enteral administration ,Gastrointestinal Hormones ,Rats, Sprague-Dawley ,Insulin-Like Growth Factor II ,Epidermal growth factor ,Internal medicine ,Animals ,Medicine ,Peptide YY ,Insulin-Like Growth Factor I ,Intestinal Mucosa ,Epidermal Growth Factor ,business.industry ,Gastroenterology ,Transforming Growth Factor alpha ,Rats ,Intestines ,Endocrinology ,Glutamine supplementation ,Surgery ,Intestinal resection ,business - Abstract
Background: Intestinal resection stimulates the synthesis and release of gastrointestinal peptides that regulate the growth and adaptation of the mucosa. Luminal nutrients are necessary for optimal proliferation and glutamine is the preferential nutrient to the small bowel. The interplay between glutamine and regulatory peptides could be important in treating short bowel syndrome. Methods: 63 Sprague-Dawley rats were divided into 3 groups: resection; transection, or controls. After intestinal resection animals were orally fed either a diet without glutamine or a glutamine-supplemented diet for 2 days. Transected animals and controls without prior surgery were fed the same two diets. Epidermal growth factor (EGF), transforming growth factor-α, insulin-like growth factors I and II (IGF-I and IGF-II), peptide YY (PYY), and enteroglucagon were analyzed in mucosa from the proximal jejunum, distal ileum as well as in portal plasma when the animals were euthanized 72 h after surgery. Results: Intestinal resection resulted in an early increase in portal plasma concentrations of PYY, EGF, enteroglucagon, and mucosal IGF-II and EGF content that were significant in glutamine-treated animals. Glutamine significantly increased PYY in portal blood after resection (p < 0.05). Conclusion: Glutamine could be of importance for the functional adaptation of residual small bowel mucosa by increasing PYY release.
- Published
- 1999
42. Sufficiency of postprandial plasma levels of islet amyloid polypeptide for suppression of feeding in rats
- Author
-
Jörgen Larsson, Johan Permert, Thomas E. Adrian, U. Arnelo, and Roger D. Reidelberger
- Subjects
Male ,Amyloid ,endocrine system ,medicine.medical_specialty ,Physiology ,media_common.quotation_subject ,Appetite ,Amylin ,Peptide hormone ,Physiology (medical) ,Internal medicine ,medicine ,Animals ,Rats, Wistar ,Infusions, Intravenous ,media_common ,geography ,Meal ,geography.geographical_feature_category ,Chemistry ,Radioimmunoassay ,Feeding Behavior ,Postprandial Period ,Islet ,Islet Amyloid Polypeptide ,Rats ,Endocrinology ,Postprandial - Abstract
Our objective was to study whether islet amyloid polypeptide (IAPP) produces satiety by an endocrine mechanism. We used a rat model to determine whether postprandial plasma levels of IAPP are comparable to those required to inhibit feeding when IAPP is administered by continuous intravenous infusion. Food intake in rats with aortic catheters increased plasma IAPP levels from a fasting level of 10.8 ± 0.5 pM to a peak level of 19.0 ± 1.0 pM at 2.2 ± 0.5 h. In rats with jugular vein and aortic catheters, the threshold intravenous dose for IAPP suppression of feeding was between 1 and 3 pmol ⋅ kg−1 ⋅ min−1. The 3 pmol ⋅ kg−1 ⋅ min−1dose decreased 4-h intake by ∼25% by decreasing meal frequency rather than meal size. This dose increased plasma IAPP by ∼24 pM. These results suggest that postprandial plasma levels of IAPP are not quite sufficient to independently produce satiety.
- Published
- 1998
43. Endoscopic evaluation of the pancreatic duct system: Opportunities offered by novel technology
- Author
-
Lars Lundell, Nils Albiin, Urban Arnelo, Søren Meisner, Johan Permert, and Lars Enochsson
- Subjects
Male ,Pancreatic duct ,medicine.medical_specialty ,Magnetic resonance cholangiopancreatography ,Outer diameter ,Endoscopic retrograde cholangiopancreatography ,medicine.diagnostic_test ,business.industry ,General surgery ,Pancreatic Ducts ,Gastroenterology ,Pancreatic Diseases ,Middle Aged ,medicine.disease ,Endoscopy ,Endoscopes, Gastrointestinal ,medicine.anatomical_structure ,Biliary tract ,medicine ,Humans ,Pancreatitis ,Endoscopy, Digestive System ,Radiology ,business ,Duct (anatomy) - Abstract
The development of front-line endoscopic technology has introduced new opportunities during endoscopic retrograde cholangiopancreatography (ERCP) to single-handedly allow direct inspection of detailed structures of the biliary and even the pancreatic duct. This paper presents a new flexible technology delivered with an outer diameter of 0.9 mm giving an image transmission of 6000 pixels. We report on a case where direct inspection of an alleged duct defect, of potential pathogenetic significance, was considered essential in order to substantiate the subsequent clinical management.
- Published
- 2007
44. An Increase in Mucosal Insulin-like Growth Factor II Content in Postresectional Rat Intestine Suggests Autocrine or Paracrine Growth Stimulation
- Author
-
Mikael Wirén, Thomas E. Adrian, P. Staab, Urban Arnelo, Johan Permert, and Jörgen Larsson
- Subjects
Male ,medicine.medical_specialty ,Time Factors ,Glutamine ,Glucagon-Like Peptides ,Enteroglucagon ,Biology ,Neuroendocrinology ,Rats, Sprague-Dawley ,Paracrine signalling ,Ileum ,Insulin-Like Growth Factor II ,Internal medicine ,medicine ,Animals ,Peptide YY ,Secretion ,Intestinal Mucosa ,Growth Substances ,Autocrine signalling ,Gastroenterology ,Adaptation, Physiological ,Small intestine ,Rats ,Portal System ,Jejunum ,Endocrinology ,medicine.anatomical_structure - Abstract
Luminal nutrients and growth factors regulate postresectional intestinal growth. The interplay between glutamine and regulatory gastrointestinal peptides is not known.The effects of intestinal resection on tissue and plasma concentrations of peptides were studied in 60 Sprague-Dawley rats divided into resected, transected, or unoperated groups. Subgroups were fed either a glutamine-free or a glutamine-supplemented diet for 7 days. Epidermal growth factor, transforming growth factor-alpha, insulin-like growth factors (IGF) I and II, peptide YY (PYY), and enteroglucagon were analyzed in intestinal mucosa and in portal plasma by radioimmunoassay.No glutamine-specific effects were seen. The mucosal content of IGF-II (P0.01) and the portal levels of enteroglucagon and PYY (P0.05-0.01) increased after intestinal resection.The increase in PYY and enteroglucagon in portal blood supports a hormonal role in the postresectional adaptation. The increase in IGF II in the ileal mucosa, without changes in plasma, implies autocrine or paracrine growth stimulation at this stage after resection.
- Published
- 1998
45. Pancreatic cancer cells selectively stimulate islet β cells to secrete amylin
- Author
-
Thomas E. Adrian, Peter R. Flatt, Xian-Zhong Ding, and Johan Permert
- Subjects
Amyloid ,endocrine system ,medicine.medical_specialty ,Pancreatic disease ,endocrine system diseases ,medicine.medical_treatment ,Amylin ,Cell Communication ,macromolecular substances ,Adenocarcinoma ,Biology ,Cell Line ,Islets of Langerhans ,Insulin resistance ,Pancreatic cancer ,Internal medicine ,medicine ,Humans ,Secretion ,geography ,geography.geographical_feature_category ,Hepatology ,Insulin ,Gastroenterology ,medicine.disease ,Islet ,Coculture Techniques ,Islet Amyloid Polypeptide ,Pancreatic Neoplasms ,Endocrinology ,medicine.anatomical_structure ,Pancreas - Abstract
Background & Aims: Patients with pancreatic adenocarcinoma have a high incidence of diabetes, profound insulin resistance, and high circulating amylin concentrations. It was hypothesized that pancreatic cancer cells produce a factor that stimulates islets to secrete amylin but not insulin. Methods: Amylin and insulin secretion were measured after coculture of pancreatic cancer cells with β cells (BRIN-BD11). The factor responsible was characterized by exposing β cells to cancer cell–conditioned medium. Results: Coculture with pancreatic (PANC-1 HPAF, and MiaPaCa2) but not colonic cancer cells (Colo 320) significantly increased amylin secretion but did not change insulin output. This effect was both time and cell number dependent. Coculture with PANC-1 or HPAF cells significantly decreased intracellular amylin, but not insulin, content. PANC-1 or HPAF cell–conditioned medium also increased amylin secretion and decreased intracellular amylin content. The factor responsible was extracted under both neutral and acidic conditions, was heat labile, and had a molecular weight of 1500. Conclusions: A soluble factor from pancreatic cancer cells selectively stimulates amylin secretion from islet cells, explaining the excessive amylin secretion found in pancreatic cancer. Because elevation of amylin concentration is an early feature of pancreatic cancer, characterization and measurement of the tumor-derived amylin-releasing factor might be valuable in the early detection of this disease. GASTROENTEROLOGY 1998;114:130-138
- Published
- 1998
46. Chronic Low Dose Islet Amyloid Polypeptide Infusion Reduces Food Intake, But Does Not Influence Glucose Metabolism, in Unrestrained Conscious Rats: Studies Using a Novel Aortic Catheterization Technique*
- Author
-
Johan Permert, Thomas E. Adrian, U. Arnelo, Catarina Arnelo, Jörgen Larsson, and Roger D. Reidelberger
- Subjects
Blood Glucose ,Male ,Amyloid ,Catheterization, Central Venous ,endocrine system ,medicine.medical_specialty ,Consciousness ,medicine.medical_treatment ,Radioimmunoassay ,Carbohydrate metabolism ,Eating ,Catheters, Indwelling ,Endocrinology ,In vivo ,Hyperinsulinism ,Internal medicine ,Infusion Procedure ,medicine ,Animals ,Infusions, Intra-Arterial ,Insulin ,Rats, Wistar ,geography ,Cross-Over Studies ,geography.geographical_feature_category ,Dose-Response Relationship, Drug ,Chemistry ,Pancreatic islets ,Islet ,In vitro ,Islet Amyloid Polypeptide ,Rats ,Glucose ,medicine.anatomical_structure - Abstract
Islet amyloid polypeptide (IAPP) is a 37-amino acid polypeptide coproduced with insulin in the beta-cells of the pancreatic islets. The physiological effects of IAPP have not been established. Although effects on glucose metabolism are seen only at pharmacological doses both in vitro and in vivo, effects on food intake have been shown at near-physiological concentrations. The aim of the present study was to investigate the effects of similar elevations of circulating plasma IAPP levels on glucose metabolism in rats and to evaluate the function of a novel aortic catheterization technique. In a cross-over design, two sets of experiments in which conscious unrestrained rats received chronic IAPP infusions at 0 and 2 or 0 and 7 pmol/kg min were performed. Peripheral glucose disposal was determined by means of the hyperinsulinemic euglycemic clamp technique. Chronic elevations of circulating IAPP at concentrations that reduced food intake [43.5 +/- 6.2 g (control) vs. 35.7 +/- 8.2 g (IAPP; P0.01) and 34.0 +/- 2.2 g (control) vs. 28.8 +/- 1.4 g (IAPP; P = 0.07) for the 7 and 2 pmol/kg x min experiments, respectively] had no effect on the glucose metabolic rate [GMR; 18.5 +/- 0.6 mmol/kg x h (control) vs. 18.7 +/- 0.9 mmol/kg x h (IAPP) and 14.4 +/- 0.7 mmol/kg x h (control) vs. 15.6 +/- 0.7 mmol/kg x h (IAPP) for the 7 and 2 pmol/kg x min experiments, respectively]. Thus, effects on glucose metabolism are unlikely to explain the anorectic effect of IAPP.
- Published
- 1997
47. Islet Hormone Secretion in Pancreatic Cancer Patients with Diabetes
- Author
-
Thomas E. Adrian, A.B. Fruin, Jörgen Larsson, Kazuhiko Tatemoto, Johan Permert, H. Von Schenck, and Margery K. Herrington
- Subjects
Male ,endocrine system ,medicine.medical_specialty ,Pancreatic disease ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Adenocarcinoma ,Glucagon ,Diabetes Complications ,Impaired glucose tolerance ,Islets of Langerhans ,Endocrinology ,Internal medicine ,Pancreatic cancer ,Diabetes mellitus ,Diabetes Mellitus ,Internal Medicine ,medicine ,Humans ,Aged ,Glucose tolerance test ,Hepatology ,medicine.diagnostic_test ,business.industry ,Fasting ,Glucose Tolerance Test ,Middle Aged ,Pancreatic Hormones ,medicine.disease ,Pancreatic Neoplasms ,medicine.anatomical_structure ,Hyperglycemia ,Pancreatectomy ,Glucose Clamp Technique ,Female ,Pancreas ,business - Abstract
The diabetes or impaired glucose tolerance that occurs in most patients with pancreatic cancer is characterized by profound insulin resistance. Recent evidence suggests that the diabetes may result from the presence of the tumor rather than being a predisposing factor to development of the malignancy. Some islet hormones have been shown to exhibit diabetogenic effects. To investigate the potential role of these hormones in the diabetic state associated with pancreatic cancer, we measured islet hormones during fasting in pancreatic cancer patients (n = 30), patients with other malignancies (n = 43), and healthy controls (n = 25). Preoperative pancreatic cancer patients were classified as normal glucose tolerance (NGTT), impaired glucose tolerance (IGTT), non-insulin-requiring diabetes (NIRD), and insulin-requiring diabetes (IRD). Nine pancreatic cancer patients were studied after tumor removal by subtotal pancreatectomy. Some preoperative pancreatic cancer patients (n = 19), postoperative patients (n = 9), and controls (n = 8) were also studied during hyperglycemia and following glucagon injection. Fasting plasma C-peptide was elevated in NIRD pancreatic cancer patients compared to controls. Fasting levels of islet amyloid polypeptide (IAPP), glucagon, and somatostatin were elevated in NIRD and IRD patients. IAPP and glucagon, but not somatostatin, normalized following subtotal pancreatectomy. During hyperglycemia, increases in C-peptide and IAPP were seen only in controls and in NGTT and postoperative pancreatic cancer patients. After glucagon infusion, IAPP levels increased in controls and nondiabetic cancer patients; C-peptide levels increased in controls, nondiabetic patients, and NIRD. Responses of C-peptide and IAPP to glucagon normalized after pancreatectomy. During hyperglycemia, glucagon levels fell in all groups except IGTT patients and a decrease in somatostatin concentrations was seen in controls.
- Published
- 1997
48. Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines
- Author
-
Feng Wang, Per Westermark, Jörgen Larsson, Thomas Gasslander, Johan Permert, Avni Abdiu, and Thomas E. Adrian
- Subjects
Male ,Amyloid ,endocrine system ,medicine.medical_specialty ,Pancreatic disease ,endocrine system diseases ,Adenocarcinoma ,In Vitro Techniques ,Biology ,Culture Media, Serum-Free ,Cell Line ,Rats, Sprague-Dawley ,Islets of Langerhans ,Endocrinology ,Cricetinae ,Internal medicine ,Pancreatic cancer ,Insulin Secretion ,Tumor Cells, Cultured ,medicine ,Animals ,Humans ,Insulin ,Pancreatic polypeptide ,geography ,geography.geographical_feature_category ,Pancreatic islets ,Gastroenterology ,medicine.disease ,Islet ,Islet Amyloid Polypeptide ,Rats ,Pancreatic Neoplasms ,medicine.anatomical_structure ,Oncology ,Cell culture ,Culture Media, Conditioned ,Pancreas - Abstract
The cosecretion of insulin and islet amyloid polypeptide (IAPP) is altered when isolated rat pancreatic islets are incubated in culture media conditioned by human pancreatic cancer cells.Pancreatic cancer is usually associated with impaired glucose tolerance. This study investigates the tumor-derived influence on beta-cell secretion of pancreatic islets.Four conditioned media were prepared from two human pancreatic cancer cell lines (Panc-1 and HPAF), a hamster pancreatic cancer cell line (PC-1), and a fibroblast cell line (Ag1523). Isolated rat pancreatic islets were incubated first in the conditioned media or nonconditioned control medium for 24 h, then in the same kind of media containing 100 microM carbamylcholine for 90 min. Insulin and IAPP secretion were measured by radioimmunoassay.Islets in media conditioned by Panc-1 and HPAF cells demonstrated dissociation of insulin and IAPP secretion. During 24-h incubation, the dissociation was expressed as selectively decreased insulin secretion. With addition of 100 microM carbamylcholine, the dissociation was expressed as normal secretion of insulin and hypersecretion of IAPP. As a result, the IAPP/insulin molar ratios were increased in both groups during both time periods. The islets in PC-1 and Ag1523 media did not show any significant changes in insulin and IAPP secretion.
- Published
- 1997
49. Excess glucose induces hypoxia-inducible factor-1α in pancreatic cancer cells and stimulates glucose metabolism and cell migration
- Author
-
Feng Wang, Zhiwen Liu, Karl-Gösta Sundqvist, Johan Permert, Yijie Duan, Xiaohui Jia, and Huijie Xiao
- Subjects
Cancer Research ,medicine.medical_specialty ,Snf3 ,Cell Growth Processes ,Biology ,Carbohydrate metabolism ,Protein Serine-Threonine Kinases ,Adenosine Triphosphate ,Cell Movement ,Internal medicine ,Cell Line, Tumor ,medicine ,Extracellular ,Humans ,Glycolysis ,RNA, Messenger ,RNA, Small Interfering ,Pharmacology ,Pyruvate Dehydrogenase Acetyl-Transferring Kinase ,Cell migration ,Hypoxia (medical) ,Hypoxia-Inducible Factor 1, alpha Subunit ,Pancreatic Neoplasms ,Endocrinology ,Glucose ,Oncology ,Hypoxia-inducible factors ,Hyperglycemia ,Molecular Medicine ,medicine.symptom ,Reactive Oxygen Species ,Intracellular ,Research Paper - Abstract
Pancreatic cancer patients frequently show hyperglycemia, but it is uncertain whether hyperglycemia stimulates pancreatic cancer cells. We have investigated whether excess glucose induces hypoxia-inducible factor-1α (HIF-1α) and stimulates glucose metabolism and cell migration in pancreatic cancer cells. We studied wild-type (wt) MiaPaCa2 pancreatic cancer cells and a MiaPaCa2 subline (namely si-MiaPaCa2) that had HIF-1α-specific small interfering RNA. Wt-MiaPaCa2 cells are known to be HIF-1α-positive in hypoxia and HIF-1α-negative in normoxia, whereas si-MiaPaCa2 cells are devoid of HIF-1α in both normoxia and hypoxia. We incubated these cells with different amounts of glucose and determined HIF-1α mRNA and protein by real-time polymerase chain reaction and western blotting. We determined glucose consumption, lactate production and intracellular hexokinase-II and ATP to assess glucose metabolisms and determined pyruvate dehydrogenase kinase-1, reactive oxygen species and fumarate to assess mitochondrial activities. Further, we studied cell migration using a Boyden chamber. Excess glucose (16.7−22.2mM) increased HIF-1α in hypoxic wt-MiaPaCa2 cells. HIF-1α expression increased ATP contents and inhibited mitochondrial activities. Extracellular glucose and hypoxia stimulated glucose metabolisms independent of HIF-1α. Excess glucose stimulated the migration of wt- and si-MiaPaCa2 cells in both normoxia and hypoxia. Thus, glucose stimulated cell migration independent of HIF-1α. Nevertheless, hypoxic wt-MiaPaCa2 cells showed greater migrating ability than their si-MiaPaCa2 counterparts. We conclude that (1) excess glucose increases HIF-1α and ATP in hypoxic wt-MiaPaCa2 cells, (2) extracellular glucose and hypoxia regulate glucose metabolisms independent of HIF-1α and (3) glucose stimulates cell migration by mechanisms that are both dependent on HIF-1α and independent of it.
- Published
- 2013
50. Effects of Acute and Chronic Infusion of Islet Amyloid Polypeptide on Food Intake in Rats
- Author
-
U. Arnelo, Thomas E. Adrian, Roger D. Reidelberger, Johan Permert, P. Westermark, J. E. Blevins, and Jörgen Larsson
- Subjects
Male ,Amyloid ,endocrine system ,medicine.medical_specialty ,Time Factors ,medicine.medical_treatment ,Drug Evaluation, Preclinical ,Amylin ,Carbohydrate metabolism ,Satiety Response ,Rats, Sprague-Dawley ,Eating ,Internal medicine ,medicine ,Animals ,Infusions, Intravenous ,geography ,geography.geographical_feature_category ,Dose-Response Relationship, Drug ,Chemistry ,Insulin ,Body Weight ,Gastroenterology ,Metabolism ,Islet ,Islet Amyloid Polypeptide ,Rats ,Endocrinology ,Systemic administration ,Hormone - Abstract
Islet amyloid polypeptide (IAPP), also called amylin, is a hormonal peptide produced by the islet beta-cells of the pancreas. Because the peptide is co-stored and co-released with insulin, attention has been focused on IAPP's ability to interfere with glucose metabolism. However, IAPP also has other effects, such as a reduction of food intake.In this study we investigated the dose-response effect of acute systemic administration of rat and human IAPP on food intake, and the cumulative effect of chronically increased circulating IAPP concentrations on food intake and body weight in the rat.All doses of rat IAPP investigated acutely inhibited food intake. The lowest infusion rate of 8 pmol/kg/min caused an 28% inhibition of the food intake at 2 h (p0.05). No effect of human IAPP was observed. Chronic administration of rat IAPP via an osmotic minipump during a 6-day period caused prolonged inhibitory effects on food intake and reduced body weight. During the first 3 days of infusion the food intake of the IAPP group was only 44% of the food intake of the control group (p0.001). The body weight of the IAPP group had fallen 18.6 +/- 2.7 g by day 3, in contrast to a small increase in the control group (4.0 +/- 3.1 g; p0.001). The reduction in food intake was sustained throughout the last 3 days of study (IAPP, 16.7 +/- 1.1 g/day; control, 20.6 +/- 1.5; p0.05). Similarly, the body weight still differed at the end of day 6 and, compared with day 0, was -8.7 +/- 3.7 g for the IAPP group and +10.9 +/- 4.8 for the control group (p0.01).These findings show that chronic increase of circulating IAPP levels can cause a marked reduction in both food intake and body weight and, together with the reduced food intake seen after acute administration of the peptide, indicates the possibility of IAPP functioning as a satiety factor.
- Published
- 1996
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.